epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
Apitegromab
apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Lumakras

sotorasib

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  TAB: 120 mg, 240 mg, 320 mg

Special Note

[uses, dosing may vary]
Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing including toxicity-related dose adjustments

KRAS G12C-mutated non-small cell lung CA, locally advanced or metastatic

[960 mg PO qd]
Info: for patients who have received at least 1 prior tx; do not cut/crush/chew, but may disperse tab in water

KRAS G12C-mutated colorectal CA, metastatic

[960 mg PO qd]
Info: for patients who have received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based tx; use with panitumumab; may continue as monotherapy if panitumumab permanently D/C'd; do not cut/crush/chew, but may disperse tab in water

renal dosing

[see below]
eGFR >30: no adjustment; eGFR <30: not defined
HD/PD: not defined

hepatic dosing

[see below]
Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: not defined

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@966544a
  • hypersensitivity to drug or ingredient
  • avoid: breastfeeding during tx and x1wk after D/C

Drug Interactions .

Overview

sotorasib

KRAS inhibitor

Interaction Characteristics:
  • CYP3A4 substrate
  • BCRP inhibitor
  • P-gp inhibitor, moderate
  • CYP3A4 inducer, moderate
  • gastric pH sensitive

Contraindicated

  • colchicine
  • Lumakras (sotorasib)
    +
    colchicine
    1 interaction

    Contraindicated

    sotorasib + colchicine

    CV RISK REDUCTION: consider alternative or monitor CK, myopathy s/sx; GOUT or FMF: contraindicated in pts w/ renal or hepatic impairment; otherwise, decr. colchicine dose based on indication during and x14 days after sotorasib use as follows: GOUT PROPHYLAXIS: give colchicine 0.3 mg qod-qd; ACUTE GOUT TX: give colchicine 0.6 mg x1 only; FMF: decr. max colchicine dose to 0.6 mg/day divided qd-bid: combo may incr. or decr. colchicine levels, incr. risk of myopathy, rhabdomyolysis, other life-threatening toxicity or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • lonafarnib
  • Lumakras (sotorasib)
    +
    lonafarnib
    1 interaction

    Contraindicated

    sotorasib + lonafarnib

    contraindicated: combo may decr. lonafarnib levels, efficacy (hepatic metabolism induced)

  • mavacamten
  • Lumakras (sotorasib)
    +
    mavacamten
    1 interaction

    Contraindicated

    sotorasib + mavacamten

    contraindicated: combo may decr. levels, efficacy of both drugs (hepatic metabolism induced)

  • ranolazine
  • Lumakras (sotorasib)
    +
    ranolazine
    1 interaction

    Contraindicated

    sotorasib + ranolazine

    contraindicated: combo may incr. or decr. ranolazine levels, incr. risk of QT prolongation, cardiac arrhythmias, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • zoliflodacin
  • Lumakras (sotorasib)
    +
    zoliflodacin
    1 interaction

    Contraindicated

    sotorasib + zoliflodacin

    contraindicated: combo may decr. zoliflodacin levels, efficacy (hepatic metabolism induced)

Avoid/Use Alternative

  • abemaciclib
  • Lumakras (sotorasib)
    +
    abemaciclib
    1 interaction

    Avoid/Use Alternative

    sotorasib + abemaciclib

    avoid combo: combo may decr. abemaciclib levels, efficacy (hepatic metabolism induced)

  • alfentanil
  • Lumakras (sotorasib)
    +
    alfentanil
    1 interaction

    Avoid/Use Alternative

    sotorasib + alfentanil

    use alternative or consider alfentanil dose adjustment: combo may decr. alfentanil levels, efficacy (hepatic metabolism induced)

  • alpelisib
  • Lumakras (sotorasib)
    +
    alpelisib
    1 interaction

    Avoid/Use Alternative

    sotorasib + alpelisib

    use alternative: combo may incr. or decr. alpelisib levels, incr. risk of adverse effects or decr. efficacy (BCRP-mediated transport possibly inhibited, hepatic metabolism induced)

  • aluminum hydroxide
  • Lumakras (sotorasib)
    +
    aluminum hydroxide
    1 interaction

    Avoid/Use Alternative

    sotorasib + aluminum hydroxide

    use alternative or give sotorasib 4h before or 10h after aluminum hydroxide: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • apalutamide
  • Lumakras (sotorasib)
    +
    apalutamide
    1 interaction

    Avoid/Use Alternative

    sotorasib + apalutamide

    avoid combo: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • aprepitant
  • Lumakras (sotorasib)
    +
    aprepitant
    1 interaction

    Avoid/Use Alternative

    sotorasib + aprepitant

    avoid combo: combo may decr. aprepitant levels, efficacy (hepatic metabolism induced)

  • artemether/lumefantrine
  • Lumakras (sotorasib)
    +
    artemether/ lumefantrine
    1 interaction

    Avoid/Use Alternative

    sotorasib + artemether/ lumefantrine

    avoid combo: combo may decr. artemether/lumefantrine levels, efficacy (hepatic metabolism induced)

  • atazanavir
  • Lumakras (sotorasib)
    +
    atazanavir
    1 interaction

    Avoid/Use Alternative

    sotorasib + atazanavir

    avoid combo: combo may decr. atazanavir levels, efficacy (hepatic metabolism induced)

  • atogepant
  • Lumakras (sotorasib)
    +
    atogepant
    1 interaction

    Avoid/Use Alternative

    sotorasib + atogepant

    CHRONIC MIGRAINE: avoid combo; EPISODIC MIGRAINE: incr. atogepant dose to 60 mg/day: combo may decr. atogepant levels, efficacy (hepatic metabolism induced)

  • atrasentan
  • Lumakras (sotorasib)
    +
    atrasentan
    1 interaction

    Avoid/Use Alternative

    sotorasib + atrasentan

    avoid combo: combo may decr. atrasentan levels, efficacy (hepatic metabolism induced)

  • avacopan
  • Lumakras (sotorasib)
    +
    avacopan
    1 interaction

    Avoid/Use Alternative

    sotorasib + avacopan

    avoid combo: combo may decr. avacopan levels, efficacy (hepatic metabolism induced)

  • avapritinib
  • Lumakras (sotorasib)
    +
    avapritinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + avapritinib

    avoid combo: combo may decr. avapritinib levels, efficacy (hepatic metabolism induced)

  • avatrombopag
  • Lumakras (sotorasib)
    +
    avatrombopag
    1 interaction

    Avoid/Use Alternative

    sotorasib + avatrombopag

    consider alternative: combo may incr. or decr. avatrombopag levels, incr. risk of thromboembolism, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • axitinib
  • Lumakras (sotorasib)
    +
    axitinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + axitinib

    avoid combo: combo may decr. axitinib levels, efficacy (hepatic metabolism induced)

  • bedaquiline
  • Lumakras (sotorasib)
    +
    bedaquiline
    1 interaction

    Avoid/Use Alternative

    sotorasib + bedaquiline

    avoid combo: combo may decr. bedaquiline levels, efficacy (hepatic metabolism induced)

  • bictegravir
  • Lumakras (sotorasib)
    +
    bictegravir
    1 interaction

    Avoid/Use Alternative

    sotorasib + bictegravir

    use alternative if also combined w/ UGT1A1 inducer: combo may decr. bictegravir levels, efficacy (hepatic metabolism induced)

  • bosutinib
  • Lumakras (sotorasib)
    +
    bosutinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + bosutinib

    avoid combo: combo may decr. bosutinib levels, efficacy (hepatic metabolism induced)

  • brigatinib
  • Lumakras (sotorasib)
    +
    brigatinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + brigatinib

    use alternative or incr. brigatinib daily dose after 7 days of concomitant tx; incr. by 30 mg increments q7 days as tolerated up to 2x maintenance dose: combo may decr. brigatinib levels, efficacy (hepatic metabolism induced)

  • buprenorphine
  • Lumakras (sotorasib)
    +
    buprenorphine
    1 interaction

    Avoid/Use Alternative

    sotorasib + buprenorphine

    use alternative or monitor withdrawal sx: combo may decr. buprenorphine levels, efficacy (hepatic metabolism induced)

  • buspirone
  • Lumakras (sotorasib)
    +
    buspirone
    1 interaction

    Avoid/Use Alternative

    sotorasib + buspirone

    consider alternative or adjust buspirone dose: combo may decr. buspirone levels, efficacy (hepatic metabolism induced)

  • butalbital
  • Lumakras (sotorasib)
    +
    butalbital
    1 interaction

    Avoid/Use Alternative

    sotorasib + butalbital

    avoid combo: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • cabozantinib
  • Lumakras (sotorasib)
    +
    cabozantinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + cabozantinib

    use alternative or incr. cabozantinib daily dose by 20 mg if renal cell CA, hepatocellular CA, differentiated thyroid CA, or NET use; consider cabozantinib dose adjustment if medullary thyroid CA use: combo may decr. cabozantinib levels, efficacy (hepatic metabolism induced)

  • calcium carbonate
  • Lumakras (sotorasib)
    +
    calcium carbonate
    1 interaction

    Avoid/Use Alternative

    sotorasib + calcium carbonate

    use alternative or give sotorasib 4h before or 10h after calcium carbonate: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • capivasertib
  • Lumakras (sotorasib)
    +
    capivasertib
    1 interaction

    Avoid/Use Alternative

    sotorasib + capivasertib

    avoid combo: combo may decr. capivasertib levels, efficacy (hepatic metabolism induced)

  • capmatinib
  • Lumakras (sotorasib)
    +
    capmatinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + capmatinib

    avoid combo: combo may decr. capmatinib levels, efficacy (hepatic metabolism induced)

  • carbamazepine
  • Lumakras (sotorasib)
    +
    carbamazepine
    1 interaction

    Avoid/Use Alternative

    sotorasib + carbamazepine

    avoid combo: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • cariprazine
  • Lumakras (sotorasib)
    +
    cariprazine
    1 interaction

    Avoid/Use Alternative

    sotorasib + cariprazine

    avoid combo: combo may decr. cariprazine and active metabolite levels, efficacy (hepatic metabolism induced)

  • cimetidine
  • Lumakras (sotorasib)
    +
    cimetidine
    1 interaction

    Avoid/Use Alternative

    sotorasib + cimetidine

    avoid combo: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • cladribine oral
  • Lumakras (sotorasib)
    +
    cladribine oral
    1 interaction

    Avoid/Use Alternative

    sotorasib + cladribine oral

    use alternative or monitor CBC: combo may incr. cladribine levels, risk of serious infection, myelosuppression, other adverse effects (gut BCRP-mediated transport inhibited)

  • clarithromycin
  • Lumakras (sotorasib)
    +
    clarithromycin
    1 interaction

    Avoid/Use Alternative

    sotorasib + clarithromycin

    use alternative: combo may decr. clarithromycin levels, efficacy (hepatic metabolism induced)

  • cobicistat
  • Lumakras (sotorasib)
    +
    cobicistat
    1 interaction

    Avoid/Use Alternative

    sotorasib + cobicistat

    avoid combo: combo may decr. cobicistat levels, efficacy (hepatic metabolism induced)

  • cobimetinib
  • Lumakras (sotorasib)
    +
    cobimetinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + cobimetinib

    avoid combo: combo may decr. cobimetinib levels, efficacy (hepatic metabolism induced)

  • codeine
  • Lumakras (sotorasib)
    +
    codeine
    1 interaction

    Avoid/Use Alternative

    sotorasib + codeine

    use alternative or monitor withdrawal sx: combo may decr. codeine and active metabolite morphine levels, efficacy (hepatic metabolism induced, may decr. production of active metabolite morphine)

  • crizotinib
  • Lumakras (sotorasib)
    +
    crizotinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + crizotinib

    avoid combo: combo may decr. crizotinib levels, efficacy (hepatic metabolism induced)

  • dabigatran
  • Lumakras (sotorasib)
    +
    dabigatran
    1 interaction

    Avoid/Use Alternative

    sotorasib + dabigatran

    ATRIAL FIBRILLATION: avoid combo if CrCl <30 mL/min; OTHER INDICATIONS: avoid combo if CrCl <50 mL/min; if dabigatran use for DVT/PE prophylaxis post-hip replacement and CrCl >50 mL/min, consider separating admin. at least 2h apart: combo may incr. dabigatran levels, risk of bleeding (including life-threatening), other adverse effects (P-gp-mediated transport inhibited)

  • daridorexant
  • Lumakras (sotorasib)
    +
    daridorexant
    1 interaction

    Avoid/Use Alternative

    sotorasib + daridorexant

    avoid combo: combo may decr. daridorexant levels, efficacy (hepatic metabolism induced)

  • darolutamide
  • Lumakras (sotorasib)
    +
    darolutamide
    1 interaction

    Avoid/Use Alternative

    sotorasib + darolutamide

    avoid combo if also combined w/ P-gp inducer; otherwise, caution advised: combo may incr. or decr. darolutamide levels, incr. risk of adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • defactinib
  • Lumakras (sotorasib)
    +
    defactinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + defactinib

    avoid combo: combo may decr. defactinib levels, efficacy (hepatic metabolism induced)

  • deflazacort
  • Lumakras (sotorasib)
    +
    deflazacort
    1 interaction

    Avoid/Use Alternative

    sotorasib + deflazacort

    avoid combo: combo may decr. deflazacort active metabolite levels, efficacy (hepatic metabolism induced)

  • desogestrel (contraceptive)
  • Lumakras (sotorasib)
    +
    desogestrel (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + desogestrel (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. desogestrel levels, contraceptive efficacy (hepatic metabolism induced)

  • dexlansoprazole
  • Lumakras (sotorasib)
    +
    dexlansoprazole
    1 interaction

    Avoid/Use Alternative

    sotorasib + dexlansoprazole

    avoid combo: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • diazoxide
  • Lumakras (sotorasib)
    +
    diazoxide
    1 interaction

    Avoid/Use Alternative

    sotorasib + diazoxide

    avoid combo if also combined w/ moderate or strong CYP1A2 inducer; otherwise, caution advised: combo may decr. diazoxide levels, efficacy (hepatic metabolism induced)

  • dienogest (contraceptive)
  • Lumakras (sotorasib)
    +
    dienogest (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + dienogest (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. dienogest levels, contraceptive efficacy (hepatic metabolism induced)

  • dihydrocodeine
  • Lumakras (sotorasib)
    +
    dihydrocodeine
    1 interaction

    Avoid/Use Alternative

    sotorasib + dihydrocodeine

    use alternative or monitor withdrawal sx: combo may decr. dihydrocodeine and active metabolite dihydromorphine levels, efficacy (hepatic metabolism induced, may decr. production of active metabolite dihydromorphine)

  • diltiazem
  • Lumakras (sotorasib)
    +
    diltiazem
    1 interaction

    Avoid/Use Alternative

    sotorasib + diltiazem

    use alternative: combo may decr. diltiazem levels, efficacy (hepatic metabolism induced)

  • dolutegravir
  • Lumakras (sotorasib)
    +
    dolutegravir
    1 interaction

    Avoid/Use Alternative

    sotorasib + dolutegravir

    avoid combo: combo may decr. dolutegravir levels, efficacy (hepatic metabolism induced)

  • doravirine
  • Lumakras (sotorasib)
    +
    doravirine
    1 interaction

    Avoid/Use Alternative

    sotorasib + doravirine

    avoid combo: combo may decr. doravirine levels, efficacy (hepatic metabolism induced)

  • dordaviprone
  • Lumakras (sotorasib)
    +
    dordaviprone
    1 interaction

    Avoid/Use Alternative

    sotorasib + dordaviprone

    avoid combo: combo may decr. dordaviprone levels, efficacy (hepatic metabolism induced)

  • doxorubicin
  • Lumakras (sotorasib)
    +
    doxorubicin
    1 interaction

    Avoid/Use Alternative

    sotorasib + doxorubicin

    avoid combo: combo may incr. or decr. doxorubicin levels, incr. risk of serious infection, myelosuppression, cardiotoxicity other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • dronedarone
  • Lumakras (sotorasib)
    +
    dronedarone
    1 interaction

    Avoid/Use Alternative

    sotorasib + dronedarone

    avoid combo: combo may decr. dronedarone levels, efficacy (hepatic metabolism induced)

  • drospirenone (contraceptive)
  • Lumakras (sotorasib)
    +
    drospirenone (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + drospirenone (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. drospirenone levels, contraceptive efficacy (hepatic metabolism induced)

  • duvelisib
  • Lumakras (sotorasib)
    +
    duvelisib
    1 interaction

    Avoid/Use Alternative

    sotorasib + duvelisib

    use alternative or incr. duvelisib dose on day 12 of sotorasib tx as follows: if on duvelisib 25 mg bid, incr. to 40 mg bid; if on duvelisib 15 mg bid, incr. to 25 mg bid: combo may decr. duvelisib levels, efficacy (hepatic metabolism induced)

  • elacestrant
  • Lumakras (sotorasib)
    +
    elacestrant
    1 interaction

    Avoid/Use Alternative

    sotorasib + elacestrant

    avoid combo: combo may decr. elacestrant levels, efficacy (hepatic metabolism induced)

  • elbasvir
  • Lumakras (sotorasib)
    +
    elbasvir
    1 interaction

    Avoid/Use Alternative

    sotorasib + elbasvir

    avoid combo: combo may decr. elbasvir levels, efficacy (hepatic metabolism induced)

  • elexacaftor/tezacaftor/ivacaftor
  • Lumakras (sotorasib)
    +
    elexacaftor/ tezacaftor/ ivacaftor
    1 interaction

    Avoid/Use Alternative

    sotorasib + elexacaftor/ tezacaftor/ ivacaftor

    avoid combo: combo may decr. elexacaftor/tezacaftor/ivacaftor levels, efficacy (hepatic metabolism induced)

  • elinzanetant
  • Lumakras (sotorasib)
    +
    elinzanetant
    1 interaction

    Avoid/Use Alternative

    sotorasib + elinzanetant

    avoid combo: combo may decr. elinzanetant levels, efficacy (hepatic metabolism induced)

  • elvitegravir
  • Lumakras (sotorasib)
    +
    elvitegravir
    1 interaction

    Avoid/Use Alternative

    sotorasib + elvitegravir

    avoid combo: combo may decr. elvitegravir levels, efficacy (hepatic metabolism induced)

  • encorafenib
  • Lumakras (sotorasib)
    +
    encorafenib
    1 interaction

    Avoid/Use Alternative

    sotorasib + encorafenib

    avoid combo: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • ensartinib
  • Lumakras (sotorasib)
    +
    ensartinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + ensartinib

    avoid combo: combo may incr. or decr. ensartinib levels, incr. risk of bradycardia, hyperglycemia, other adverse effects or decr. efficacy (P-gp-mediated transport possibly inhibited, hepatic metabolism possibly induced)

  • entrectinib
  • Lumakras (sotorasib)
    +
    entrectinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + entrectinib

    avoid combo: combo may decr. entrectinib levels, efficacy (hepatic metabolism induced)

  • enzalutamide
  • Lumakras (sotorasib)
    +
    enzalutamide
    1 interaction

    Avoid/Use Alternative

    sotorasib + enzalutamide

    avoid combo: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • erdafitinib
  • Lumakras (sotorasib)
    +
    erdafitinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + erdafitinib

    use alternative or initiate erdafitinib at 9 mg qd: combo may decr. erdafitinib levels, efficacy (hepatic metabolism induced)

  • erlotinib
  • Lumakras (sotorasib)
    +
    erlotinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + erlotinib

    use alternative or incr. erlotinib dose by 50mg/day q2wk up to 450 mg/day: combo may decr. erlotinib levels, efficacy (hepatic metabolism induced)

  • esomeprazole
  • Lumakras (sotorasib)
    +
    esomeprazole
    1 interaction

    Avoid/Use Alternative

    sotorasib + esomeprazole

    avoid combo: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced, absorption decreased at higher gastric pH)

  • estradiol (contraceptive)
  • Lumakras (sotorasib)
    +
    estradiol (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + estradiol (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. estradiol levels, contraceptive efficacy (hepatic metabolism induced)

  • ethinyl estradiol (contraceptive)
  • Lumakras (sotorasib)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + ethinyl estradiol (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. ethinyl estradiol levels, contraceptive efficacy (hepatic metabolism induced)

  • ethynodiol (contraceptive)
  • Lumakras (sotorasib)
    +
    ethynodiol (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + ethynodiol (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. ethynodiol and active metabolite levels, contraceptive efficacy (hepatic metabolism induced)

  • etonogestrel (contraceptive)
  • Lumakras (sotorasib)
    +
    etonogestrel (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + etonogestrel (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. etonogestrel levels, contraceptive efficacy (hepatic metabolism induced)

  • everolimus
  • Lumakras (sotorasib)
    +
    everolimus
    1 interaction

    Avoid/Use Alternative

    sotorasib + everolimus

    BREAST CA, PNET, RENAL CELL CA, RENAL ANGIOMYOLIPOMA W/ TSC: if also combined w/ P-gp inducer, use alternative or consider everolimus dose adjustment; otherwise, monitor CBC; TSC-ASSOC. SEGA or TSC-ASSOC. PARTIAL-ONSET SEIZURES: if also combined w/ P-gp inducer, consider everolimus dose adjustment and monitor everolimus levels, CBC; otherwise, monitor everolimus levels, CBC; TRANSPLANT: use alternative or monitor everolimus levels, CBC: combo may incr. or decr. everolimus levels, incr. risk of serious infection, myelosuppression, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • famotidine
  • Lumakras (sotorasib)
    +
    famotidine
    1 interaction

    Avoid/Use Alternative

    sotorasib + famotidine

    avoid combo: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • fedratinib
  • Lumakras (sotorasib)
    +
    fedratinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + fedratinib

    avoid combo: combo may decr. fedratinib levels, efficacy (hepatic metabolism induced)

  • felodipine
  • Lumakras (sotorasib)
    +
    felodipine
    1 interaction

    Avoid/Use Alternative

    sotorasib + felodipine

    use alternative: combo may decr. felodipine levels, efficacy (hepatic metabolism induced)

  • fentanyl
  • Lumakras (sotorasib)
    +
    fentanyl
    1 interaction

    Avoid/Use Alternative

    sotorasib + fentanyl

    use alternative or monitor withdrawal sx: combo may decr. fentanyl levels, efficacy (hepatic metabolism induced)

  • finerenone
  • Lumakras (sotorasib)
    +
    finerenone
    1 interaction

    Avoid/Use Alternative

    sotorasib + finerenone

    avoid combo: combo may decr. finerenone levels, efficacy (hepatic metabolism induced)

  • fosamprenavir
  • Lumakras (sotorasib)
    +
    fosamprenavir
    1 interaction

    Avoid/Use Alternative

    sotorasib + fosamprenavir

    avoid combo: combo may decr. amprenavir levels, efficacy (hepatic metabolism induced)

  • fosaprepitant
  • Lumakras (sotorasib)
    +
    fosaprepitant
    1 interaction

    Avoid/Use Alternative

    sotorasib + fosaprepitant

    avoid combo: combo may decr. aprepitant levels, efficacy (hepatic metabolism induced)

  • fosphenytoin
  • Lumakras (sotorasib)
    +
    fosphenytoin
    1 interaction

    Avoid/Use Alternative

    sotorasib + fosphenytoin

    avoid combo: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • fostamatinib
  • Lumakras (sotorasib)
    +
    fostamatinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + fostamatinib

    use alternative: combo may decr. fostamatinib active metabolite levels, efficacy (hepatic metabolism induced)

  • fruquintinib
  • Lumakras (sotorasib)
    +
    fruquintinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + fruquintinib

    use alternative: combo may decr. fruquintinib levels, efficacy (hepatic metabolism induced)

  • ganaxolone
  • Lumakras (sotorasib)
    +
    ganaxolone
    1 interaction

    Avoid/Use Alternative

    sotorasib + ganaxolone

    use alternative or consider ganaxolone dose adjustment: combo may decr. ganaxolone levels, efficacy (hepatic metabolism induced)

  • gepotidacin
  • Lumakras (sotorasib)
    +
    gepotidacin
    1 interaction

    Avoid/Use Alternative

    sotorasib + gepotidacin

    UROGENITAL GONORRHEA: avoid combo; URINARY TRACT INFECTION: caution advised: combo may decr. gepotidacin levels, efficacy (hepatic metabolism induced)

  • gilteritinib
  • Lumakras (sotorasib)
    +
    gilteritinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + gilteritinib

    avoid combo if also combined w/ P-gp inducer; otherwise, consider alternative: combo may decr. gilteritinib levels, efficacy (hepatic metabolism induced)

  • glasdegib
  • Lumakras (sotorasib)
    +
    glasdegib
    1 interaction

    Avoid/Use Alternative

    sotorasib + glasdegib

    use alternative or incr. glasdegib dose as follows: if on glasdegib 100 mg qd, incr. to 200 mg qd; if on glasdegib 50 mg qd, incr. to 100 mg qd: combo may decr. glasdegib levels, efficacy (hepatic metabolism induced)

  • glecaprevir
  • Lumakras (sotorasib)
    +
    glecaprevir
    1 interaction

    Avoid/Use Alternative

    sotorasib + glecaprevir

    avoid combo: combo may incr. or decr. glecaprevir levels, incr. risk of adverse effects or decr. efficacy (P-gp-mediated transport inhibited, BCRP-mediated transport inhibited, hepatic metabolism induced)

  • grazoprevir
  • Lumakras (sotorasib)
    +
    grazoprevir
    1 interaction

    Avoid/Use Alternative

    sotorasib + grazoprevir

    avoid combo: combo may decr. grazoprevir levels, efficacy (hepatic metabolism induced)

  • hydrocodone
  • Lumakras (sotorasib)
    +
    hydrocodone
    1 interaction

    Avoid/Use Alternative

    sotorasib + hydrocodone

    use alternative or monitor withdrawal sx: combo may decr. hydrocodone levels, efficacy (hepatic metabolism induced)

  • ibrexafungerp
  • Lumakras (sotorasib)
    +
    ibrexafungerp
    1 interaction

    Avoid/Use Alternative

    sotorasib + ibrexafungerp

    avoid combo: combo may decr. ibrexafungerp levels, efficacy (hepatic metabolism induced)

  • ibrutinib
  • Lumakras (sotorasib)
    +
    ibrutinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + ibrutinib

    avoid combo: combo may decr. ibrutinib levels, efficacy (hepatic metabolism induced)

  • idelalisib
  • Lumakras (sotorasib)
    +
    idelalisib
    1 interaction

    Avoid/Use Alternative

    sotorasib + idelalisib

    avoid combo: combo may decr. idelalisib levels, efficacy (hepatic metabolism induced)

  • imatinib
  • Lumakras (sotorasib)
    +
    imatinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + imatinib

    use alternative or consider imatinib dose adjustment: combo may decrease imatinib levels, efficacy (hepatic metabolism induced)

  • irinotecan
  • Lumakras (sotorasib)
    +
    irinotecan
    1 interaction

    Avoid/Use Alternative

    sotorasib + irinotecan

    use alternative or D/C sotorasib >2wk prior to irinotecan start: combo may incr. or decr. irinotecan and active metabolite levels, incr. risk of serious infection, myelosuppression, other toxicities or decr. efficacy (hepatic metabolism induced, BCRP-mediated transport inhibited)

  • isavuconazonium
  • Lumakras (sotorasib)
    +
    isavuconazonium
    1 interaction

    Avoid/Use Alternative

    sotorasib + isavuconazonium

    avoid combo: combo may decr. isavuconazole levels, efficacy (hepatic metabolism induced)

  • isradipine
  • Lumakras (sotorasib)
    +
    isradipine
    1 interaction

    Avoid/Use Alternative

    sotorasib + isradipine

    consider alternative: combo may decr. isradipine levels, efficacy (hepatic metabolism induced)

  • istradefylline
  • Lumakras (sotorasib)
    +
    istradefylline
    1 interaction

    Avoid/Use Alternative

    sotorasib + istradefylline

    avoid combo: combo may decr. istradefylline levels, efficacy (hepatic metabolism induced)

  • itraconazole
  • Lumakras (sotorasib)
    +
    itraconazole
    1 interaction

    Avoid/Use Alternative

    sotorasib + itraconazole

    avoid combo 2wk before and during itraconazole tx: combo may decr. itraconazole levels, efficacy (hepatic metabolism induced)

  • ivacaftor
  • Lumakras (sotorasib)
    +
    ivacaftor
    1 interaction

    Avoid/Use Alternative

    sotorasib + ivacaftor

    avoid combo: combo may decr. ivacaftor levels, efficacy (hepatic metabolism induced)

  • ivosidenib
  • Lumakras (sotorasib)
    +
    ivosidenib
    1 interaction

    Avoid/Use Alternative

    sotorasib + ivosidenib

    avoid combo: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • ketoconazole
  • Lumakras (sotorasib)
    +
    ketoconazole
    1 interaction

    Avoid/Use Alternative

    sotorasib + ketoconazole

    avoid combo 2wk before and during ketoconazole tx if possible; monitor for breakthrough fungal infection; consider incr. ketoconazole dose: combo may decr. ketoconazole levels, efficacy (hepatic metabolism induced)

  • lansoprazole
  • Lumakras (sotorasib)
    +
    lansoprazole
    1 interaction

    Avoid/Use Alternative

    sotorasib + lansoprazole

    avoid combo: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • larotrectinib
  • Lumakras (sotorasib)
    +
    larotrectinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + larotrectinib

    use alternative or double larotrectinib dose: combo may decr. larotrectinib levels, efficacy (hepatic metabolism induced)

  • lazertinib
  • Lumakras (sotorasib)
    +
    lazertinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + lazertinib

    avoid combo: combo may decr. lazertinib levels, efficacy (hepatic metabolism induced)

  • lefamulin
  • Lumakras (sotorasib)
    +
    lefamulin
    1 interaction

    Avoid/Use Alternative

    sotorasib + lefamulin

    use alternative, especially w/ oral lefamulin: combo may incr. or decr. lefamulin levels, incr. risk of QT prolongation, cardiac arrhythmias, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • lemborexant
  • Lumakras (sotorasib)
    +
    lemborexant
    1 interaction

    Avoid/Use Alternative

    sotorasib + lemborexant

    avoid combo: combo may decr. lemborexant levels, efficacy (hepatic metabolism induced)

  • lenacapavir
  • Lumakras (sotorasib)
    +
    lenacapavir
    1 interaction

    Avoid/Use Alternative

    sotorasib + lenacapavir

    HIV INFECTION: avoid combo; HIV PRE-EXPOSURE PROPHYLAXIS: avoid combo if also combined w/ strong CYP3A4 and UGT1A1 inhibitors; otherwise, on day sotorasib is initiated, give supplemental lenacapavir 463.5 mg SC x1; if sotorasib use >6mo, give supplemental lenacapavir 463.5 mg SC x1 every 6mo from sotorasib initiation; consider alternative if already receiving sotorasib, dosing regimen not established: combo may incr. or decr. lenacapavir levels, incr. risk of adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • leniolisib
  • Lumakras (sotorasib)
    +
    leniolisib
    1 interaction

    Avoid/Use Alternative

    sotorasib + leniolisib

    avoid combo: combo may decr. leniolisib levels, efficacy (hepatic metabolism induced)

  • letermovir
  • Lumakras (sotorasib)
    +
    letermovir
    1 interaction

    Avoid/Use Alternative

    sotorasib + letermovir

    avoid combo: combo may decr. letermovir levels, efficacy (hepatic metabolism induced)

  • levoketoconazole
  • Lumakras (sotorasib)
    +
    levoketoconazole
    1 interaction

    Avoid/Use Alternative

    sotorasib + levoketoconazole

    consider alternative x2wk before and during levoketoconazole tx: combo may decr. levoketoconazole levels, efficacy (hepatic metabolism induced)

  • levonorgestrel (contraceptive)
  • Lumakras (sotorasib)
    +
    levonorgestrel (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + levonorgestrel (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. levonorgestrel levels, contraceptive efficacy (hepatic metabolism induced)

  • levonorgestrel (post-coital contraceptive)
  • Lumakras (sotorasib)
    +
    levonorgestrel (post-coital contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + levonorgestrel (post-coital contraceptive)

    consider alternative: combo may decr. levonorgestrel levels, post-coital contraceptive efficacy (hepatic metabolism induced)

  • lopinavir/ritonavir
  • Lumakras (sotorasib)
    +
    lopinavir/ ritonavir
    1 interaction

    Avoid/Use Alternative

    sotorasib + lopinavir/ ritonavir

    avoid combo: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • lorlatinib
  • Lumakras (sotorasib)
    +
    lorlatinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + lorlatinib

    use alternative or incr. lorlatinib dose to 125 mg qd: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • lumacaftor/ivacaftor
  • Lumakras (sotorasib)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Avoid/Use Alternative

    sotorasib + lumacaftor/ ivacaftor

    avoid combo: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • lumateperone
  • Lumakras (sotorasib)
    +
    lumateperone
    1 interaction

    Avoid/Use Alternative

    sotorasib + lumateperone

    avoid combo: combo may decr. lumateperone levels, efficacy (hepatic metabolism induced)

  • macitentan
  • Lumakras (sotorasib)
    +
    macitentan
    1 interaction

    Avoid/Use Alternative

    sotorasib + macitentan

    avoid combo: combo may decr. macitentan levels, efficacy (hepatic metabolism induced)

  • magnesium carbonate
  • Lumakras (sotorasib)
    +
    magnesium carbonate
    1 interaction

    Avoid/Use Alternative

    sotorasib + magnesium carbonate

    use alternative or give sotorasib 4h before or 10h after magnesium carbonate: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • magnesium hydroxide
  • Lumakras (sotorasib)
    +
    magnesium hydroxide
    1 interaction

    Avoid/Use Alternative

    sotorasib + magnesium hydroxide

    use alternative or give sotorasib 4h before or 10h after magnesium hydroxide: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • magnesium oxide
  • Lumakras (sotorasib)
    +
    magnesium oxide
    1 interaction

    Avoid/Use Alternative

    sotorasib + magnesium oxide

    use alternative or give sotorasib 4h before or 10h after magnesium oxide: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • maraviroc
  • Lumakras (sotorasib)
    +
    maraviroc
    1 interaction

    Avoid/Use Alternative

    sotorasib + maraviroc

    ADULTS: consider maraviroc dose adjustment; PEDS: avoid combo: combo may incr. or decr. maraviroc levels, incr. risk of adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • medroxyprogesterone (contraceptive)
  • Lumakras (sotorasib)
    +
    medroxyprogesterone (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + medroxyprogesterone (contraceptive)

    use additional non-hormonal or alternative contraception: combo may decr. medroxyprogesterone levels, contraceptive efficacy (hepatic metabolism induced)

  • meperidine
  • Lumakras (sotorasib)
    +
    meperidine
    1 interaction

    Avoid/Use Alternative

    sotorasib + meperidine

    use alternative or monitor for withdrawal sx: combo may decr. meperidine levels, efficacy; may incr. normeperidine levels, risk of neurotoxicity (hepatic metabolism induced, incr. toxic metabolite formation)

  • methadone
  • Lumakras (sotorasib)
    +
    methadone
    1 interaction

    Avoid/Use Alternative

    sotorasib + methadone

    use alternative or monitor for withdrawal sx: combo may decr. methadone levels, efficacy (hepatic metabolism induced)

  • midazolam
  • Lumakras (sotorasib)
    +
    midazolam
    1 interaction

    Avoid/Use Alternative

    sotorasib + midazolam

    use alternative to oral midazolam; other midazolam routes OK: combo may decr. midazolam levels, efficacy (hepatic metabolism induced)

  • midostaurin
  • Lumakras (sotorasib)
    +
    midostaurin
    1 interaction

    Avoid/Use Alternative

    sotorasib + midostaurin

    consider alternative: combo may decr. midostaurin levels, efficacy (hepatic metabolism induced)

  • mifepristone
  • Lumakras (sotorasib)
    +
    mifepristone
    1 interaction

    Avoid/Use Alternative

    sotorasib + mifepristone

    avoid combo if daily mifepristone use; caution advised if pregnancy termination use: combo may decr. mifepristone levels, efficacy (hepatic metabolism induced)

  • mirtazapine
  • Lumakras (sotorasib)
    +
    mirtazapine
    1 interaction

    Avoid/Use Alternative

    sotorasib + mirtazapine

    consider mirtazapine dose adjustment: combo may decr. mirtazapine levels, efficacy (hepatic metabolism induced)

  • mitapivat
  • Lumakras (sotorasib)
    +
    mitapivat
    1 interaction

    Avoid/Use Alternative

    sotorasib + mitapivat

    consider alternative; otherwise, monitor Hgb and consider mitapivat dose adjustment up to max 100 mg bid: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • mitotane
  • Lumakras (sotorasib)
    +
    mitotane
    1 interaction

    Avoid/Use Alternative

    sotorasib + mitotane

    avoid combo: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • mobocertinib
  • Lumakras (sotorasib)
    +
    mobocertinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + mobocertinib

    avoid combo: combo may decr. mobocertinib levels, efficacy (hepatic metabolism induced)

  • naldemedine
  • Lumakras (sotorasib)
    +
    naldemedine
    1 interaction

    Avoid/Use Alternative

    sotorasib + naldemedine

    use alternative: combo may incr. or decr. naldemedine levels, incr. risk of adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • naloxegol
  • Lumakras (sotorasib)
    +
    naloxegol
    1 interaction

    Avoid/Use Alternative

    sotorasib + naloxegol

    consider alternative: combo may decr. naloxegol levels, efficacy (hepatic metabolism induced)

  • nefazodone
  • Lumakras (sotorasib)
    +
    nefazodone
    1 interaction

    Avoid/Use Alternative

    sotorasib + nefazodone

    avoid combo: combo may decr. nefazodone levels, efficacy (hepatic metabolism induced)

  • nelfinavir
  • Lumakras (sotorasib)
    +
    nelfinavir
    1 interaction

    Avoid/Use Alternative

    sotorasib + nelfinavir

    avoid combo: combo may decr. nelfinavir levels, efficacy (hepatic metabolism induced)

  • nerandomilast
  • Lumakras (sotorasib)
    +
    nerandomilast
    1 interaction

    Avoid/Use Alternative

    sotorasib + nerandomilast

    avoid combo: combo may decr. nerandomilast levels, efficacy (hepatic metabolism possibly induced)

  • neratinib
  • Lumakras (sotorasib)
    +
    neratinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + neratinib

    avoid combo: combo may incr. or decr. neratinib levels, incr. risk of adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • netupitant
  • Lumakras (sotorasib)
    +
    netupitant
    1 interaction

    Avoid/Use Alternative

    sotorasib + netupitant

    consider alternative: combo may decr. netupitant levels, efficacy (hepatic metabolism induced)

  • nevirapine
  • Lumakras (sotorasib)
    +
    nevirapine
    1 interaction

    Avoid/Use Alternative

    sotorasib + nevirapine

    avoid combo: combo may decr. nevirapine levels, efficacy (hepatic metabolism induced)

  • nicardipine
  • Lumakras (sotorasib)
    +
    nicardipine
    1 interaction

    Avoid/Use Alternative

    sotorasib + nicardipine

    use alternative or monitor BP: combo may decr. nicardipine levels, efficacy (hepatic metabolism induced)

  • nifedipine
  • Lumakras (sotorasib)
    +
    nifedipine
    1 interaction

    Avoid/Use Alternative

    sotorasib + nifedipine

    use alternative: combo may decr. nifedipine levels, efficacy (hepatic metabolism induced)

  • nilotinib
  • Lumakras (sotorasib)
    +
    nilotinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + nilotinib

    consider alternative: combo may decr. nilotinib levels, efficacy (hepatic metabolism induced)

  • nirmatrelvir
  • Lumakras (sotorasib)
    +
    nirmatrelvir
    1 interaction

    Avoid/Use Alternative

    sotorasib + nirmatrelvir

    avoid combo: combo may decr. nirmatrelvir levels, efficacy (hepatic metabolism induced)

  • nirogacestat
  • Lumakras (sotorasib)
    +
    nirogacestat
    1 interaction

    Avoid/Use Alternative

    sotorasib + nirogacestat

    avoid combo: combo may decr. nirogacestat levels, efficacy (hepatic metabolism induced)

  • nisoldipine
  • Lumakras (sotorasib)
    +
    nisoldipine
    1 interaction

    Avoid/Use Alternative

    sotorasib + nisoldipine

    use alternative or monitor BP: combo may decr. nisoldipine levels, efficacy (hepatic metabolism induced)

  • nizatidine
  • Lumakras (sotorasib)
    +
    nizatidine
    1 interaction

    Avoid/Use Alternative

    sotorasib + nizatidine

    avoid combo: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • norelgestromin (contraceptive)
  • Lumakras (sotorasib)
    +
    norelgestromin (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + norelgestromin (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. norelgestromin levels, contraceptive efficacy (hepatic metabolism induced)

  • norethindrone (contraceptive)
  • Lumakras (sotorasib)
    +
    norethindrone (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + norethindrone (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. norethindrone levels, contraceptive efficacy (hepatic metabolism induced)

  • norgestimate (contraceptive)
  • Lumakras (sotorasib)
    +
    norgestimate (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + norgestimate (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. norgestimate and active metabolites levels, contraceptive efficacy (hepatic metabolism induced)

  • norgestrel (contraceptive)
  • Lumakras (sotorasib)
    +
    norgestrel (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + norgestrel (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. norgestrel levels, contraceptive efficacy (hepatic metabolism induced)

  • olaparib
  • Lumakras (sotorasib)
    +
    olaparib
    1 interaction

    Avoid/Use Alternative

    sotorasib + olaparib

    avoid combo: combo may decr. olaparib levels, efficacy (hepatic metabolism induced)

  • oliceridine
  • Lumakras (sotorasib)
    +
    oliceridine
    1 interaction

    Avoid/Use Alternative

    sotorasib + oliceridine

    use alternative or monitor withdrawal sx; consider oliceridine dose adjustment: combo may decr. oliceridine levels, efficacy (hepatic metabolism induced)

  • olutasidenib
  • Lumakras (sotorasib)
    +
    olutasidenib
    1 interaction

    Avoid/Use Alternative

    sotorasib + olutasidenib

    avoid combo: combo may decr. olutasidenib levels, efficacy (hepatic metabolism induced)

  • omaveloxolone
  • Lumakras (sotorasib)
    +
    omaveloxolone
    1 interaction

    Avoid/Use Alternative

    sotorasib + omaveloxolone

    avoid combo: combo may decr. omaveloxolone levels, efficacy (hepatic metabolism induced)

  • omeprazole
  • Lumakras (sotorasib)
    +
    omeprazole
    1 interaction

    Avoid/Use Alternative

    sotorasib + omeprazole

    avoid combo: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced, absorption decreased at higher gastric pH)

  • oxycodone
  • Lumakras (sotorasib)
    +
    oxycodone
    1 interaction

    Avoid/Use Alternative

    sotorasib + oxycodone

    use alternative or monitor withdrawal sx: combo may decr. oxycodone levels, efficacy (hepatic metabolism induced)

  • palbociclib
  • Lumakras (sotorasib)
    +
    palbociclib
    1 interaction

    Avoid/Use Alternative

    sotorasib + palbociclib

    avoid combo: combo may decr. palbociclib levels, efficacy (hepatic metabolism induced)

  • palovarotene
  • Lumakras (sotorasib)
    +
    palovarotene
    1 interaction

    Avoid/Use Alternative

    sotorasib + palovarotene

    avoid combo: combo may decr. palovarotene levels, efficacy (hepatic metabolism induced)

  • pantoprazole
  • Lumakras (sotorasib)
    +
    pantoprazole
    1 interaction

    Avoid/Use Alternative

    sotorasib + pantoprazole

    avoid combo: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • pazopanib
  • Lumakras (sotorasib)
    +
    pazopanib
    1 interaction

    Avoid/Use Alternative

    sotorasib + pazopanib

    avoid combo: combo may incr. or decr. pazopanib levels, incr. risk of QT prolongation, cardiac arrhythmias, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, BCRP-mediated transport inhibited, hepatic metabolism induced)

  • pemigatinib
  • Lumakras (sotorasib)
    +
    pemigatinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + pemigatinib

    avoid combo: combo may decr. pemigatinib levels, efficacy (hepatic metabolism induced)

  • pentobarbital
  • Lumakras (sotorasib)
    +
    pentobarbital
    1 interaction

    Avoid/Use Alternative

    sotorasib + pentobarbital

    avoid combo: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • phenobarbital
  • Lumakras (sotorasib)
    +
    phenobarbital
    1 interaction

    Avoid/Use Alternative

    sotorasib + phenobarbital

    avoid combo: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • phenytoin
  • Lumakras (sotorasib)
    +
    phenytoin
    1 interaction

    Avoid/Use Alternative

    sotorasib + phenytoin

    avoid combo: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • pimavanserin
  • Lumakras (sotorasib)
    +
    pimavanserin
    1 interaction

    Avoid/Use Alternative

    sotorasib + pimavanserin

    avoid combo: combo may decr. pimavanserin levels, efficacy (hepatic metabolism induced)

  • pirtobrutinib
  • Lumakras (sotorasib)
    +
    pirtobrutinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + pirtobrutinib

    use alternative or incr. pirtobrutinib dose as follows: if on pirtobrutinib 200 mg qd, incr. to 300 mg; if on pirtobrutinib 100 mg qd, incr. to 150 mg; if on pirtobrutinib 50 mg qd, incr. to 100 mg: combo may decr. pirtobrutinib levels, efficacy (hepatic metabolism induced)

  • ponatinib
  • Lumakras (sotorasib)
    +
    ponatinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + ponatinib

    use alternative: combo may decr. ponatinib levels, efficacy (hepatic metabolism induced)

  • pralsetinib
  • Lumakras (sotorasib)
    +
    pralsetinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + pralsetinib

    consider alternative: combo may incr. or decr. pralsetinib levels, incr. risk of QT prolongation, cardiac arrhythmias, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • praziquantel
  • Lumakras (sotorasib)
    +
    praziquantel
    1 interaction

    Avoid/Use Alternative

    sotorasib + praziquantel

    use alternative or D/C sotorasib at least 2wk prior to praziquantel start; if immediate schistosomiasis tx required, monitor anthelmintic efficacy: combo may decr. praziquantel levels, efficacy (hepatic metabolism induced)

  • pretomanid
  • Lumakras (sotorasib)
    +
    pretomanid
    1 interaction

    Avoid/Use Alternative

    sotorasib + pretomanid

    avoid combo: combo may decr. pretomanid levels, efficacy (hepatic metabolism induced)

  • primidone
  • Lumakras (sotorasib)
    +
    primidone
    1 interaction

    Avoid/Use Alternative

    sotorasib + primidone

    avoid combo: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • quizartinib
  • Lumakras (sotorasib)
    +
    quizartinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + quizartinib

    avoid combo: combo may decr. quizartinib levels, efficacy (hepatic metabolism induced)

  • rabeprazole
  • Lumakras (sotorasib)
    +
    rabeprazole
    1 interaction

    Avoid/Use Alternative

    sotorasib + rabeprazole

    avoid combo: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • relugolix
  • Lumakras (sotorasib)
    +
    relugolix
    1 interaction

    Avoid/Use Alternative

    sotorasib + relugolix

    PROSTATE CANCER: may hold relugolix if sotorasib tx up to 2wk; otherwise, use alternative or monitor ECG, electrolytes and admin. relugolix at least 6h before sotorasib; FIBROID-ASSOC. BLEEDING: use alternative or admin. relugolix at least 6h before sotorasib: combo may incr. or decr. relugolix levels, incr. risk of QT prolongation, cardiac arrhythmias, other adverse effects or decr. efficacy (gut P-gp-mediated transport inhibited, hepatic metabolism induced)

  • remibrutinib
  • Lumakras (sotorasib)
    +
    remibrutinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + remibrutinib

    avoid combo: combo may decr. remibrutinib levels, efficacy (hepatic metabolism induced)

  • repotrectinib
  • Lumakras (sotorasib)
    +
    repotrectinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + repotrectinib

    avoid combo: combo may decr. levels of both drugs, efficacy; may incr. repotrectinib levels, risk of adverse effects (hepatic metabolism induced; P-gp-mediated transport inhibited)

  • revumenib
  • Lumakras (sotorasib)
    +
    revumenib
    1 interaction

    Avoid/Use Alternative

    sotorasib + revumenib

    avoid combo: combo may decr. revumenib levels, efficacy; may incr. revumenib active metabolite levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (hepatic metabolism induced; incr. active metabolite formation)

  • ribociclib
  • Lumakras (sotorasib)
    +
    ribociclib
    1 interaction

    Avoid/Use Alternative

    sotorasib + ribociclib

    consider alternative: combo may decr. ribociclib levels, efficacy (hepatic metabolism induced)

  • rifabutin
  • Lumakras (sotorasib)
    +
    rifabutin
    1 interaction

    Avoid/Use Alternative

    sotorasib + rifabutin

    avoid combo: combo may decr. levels, efficacy of both drugs (hepatic metabolism induced)

  • rifampin
  • Lumakras (sotorasib)
    +
    rifampin
    1 interaction

    Avoid/Use Alternative

    sotorasib + rifampin

    avoid combo: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • rilpivirine
  • Lumakras (sotorasib)
    +
    rilpivirine
    1 interaction

    Avoid/Use Alternative

    sotorasib + rilpivirine

    avoid combo: combo may decr. rilpivirine levels, efficacy (hepatic metabolism induced)

  • rilzabrutinib
  • Lumakras (sotorasib)
    +
    rilzabrutinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + rilzabrutinib

    avoid combo: combo may decr. rilzabrutinib levels, efficacy (hepatic metabolism induced)

  • rimegepant
  • Lumakras (sotorasib)
    +
    rimegepant
    1 interaction

    Avoid/Use Alternative

    sotorasib + rimegepant

    avoid combo: combo may incr. or decr. rimegepant levels, incr. risk of adverse effects or decr. efficacy (P-gp-mediated transport inhibited; hepatic metabolism induced)

  • ripretinib
  • Lumakras (sotorasib)
    +
    ripretinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + ripretinib

    use alternative or incr. ripretinib dose to 150 mg bid: combo may decr. ripretinib and active metabolite levels, efficacy (hepatic metabolism induced)

  • ritonavir
  • Lumakras (sotorasib)
    +
    ritonavir
    1 interaction

    Avoid/Use Alternative

    sotorasib + ritonavir

    use alternative: combo may decr. ritonavir levels, efficacy (hepatic metabolism induced)

  • rivaroxaban
  • Lumakras (sotorasib)
    +
    rivaroxaban
    1 interaction

    Avoid/Use Alternative

    sotorasib + rivaroxaban

    avoid combo if also combined w/ strong CYP3A4 inhibitor or P-gp inducer; use alternative if CrCl <80 and combined w/ moderate CYP3A4 inhibitor; otherwise, monitor bleeding s/sx: combo may incr. or decr. rivaroxaban levels, incr. risk of bleeding, other adverse effects or decr. efficacy (BCRP-mediated transport inhibited, P-gp-mediated transport inhibited, hepatic metabolism induced)

  • roflumilast
  • Lumakras (sotorasib)
    +
    roflumilast
    1 interaction

    Avoid/Use Alternative

    sotorasib + roflumilast

    consider alternative: combo may decr. roflumilast levels, efficacy (hepatic metabolism induced)

  • rolapitant
  • Lumakras (sotorasib)
    +
    rolapitant
    1 interaction

    Avoid/Use Alternative

    sotorasib + rolapitant

    consider alternative: combo may decr. rolapitant levels, efficacy (hepatic metabolism induced)

  • samidorphan
  • Lumakras (sotorasib)
    +
    samidorphan
    1 interaction

    Avoid/Use Alternative

    sotorasib + samidorphan

    consider alternative: combo may decr. samidorphan levels, efficacy (hepatic metabolism induced)

  • sebetralstat
  • Lumakras (sotorasib)
    +
    sebetralstat
    1 interaction

    Avoid/Use Alternative

    sotorasib + sebetralstat

    avoid combo: combo may decr. sebetralstat levels, efficacy (hepatic metabolism induced)

  • segesterone (contraceptive)
  • Lumakras (sotorasib)
    +
    segesterone (contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + segesterone (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after sotorasib tx: combo may decr. segesterone levels, contraceptive efficacy (hepatic metabolism induced)

  • selpercatinib
  • Lumakras (sotorasib)
    +
    selpercatinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + selpercatinib

    avoid combo: combo may decr. selpercatinib levels, efficacy (hepatic metabolism induced)

  • selumetinib
  • Lumakras (sotorasib)
    +
    selumetinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + selumetinib

    avoid combo: combo may decr. selumetinib levels, efficacy (hepatic metabolism induced)

  • sevabertinib
  • Lumakras (sotorasib)
    +
    sevabertinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + sevabertinib

    avoid combo: combo may decr. sevabertinib levels, efficacy (hepatic metabolism induced)

  • simvastatin
  • Lumakras (sotorasib)
    +
    simvastatin
    1 interaction

    Avoid/Use Alternative

    sotorasib + simvastatin

    consider alternative: combo may incr. or decr. simvastatin levels, incr. risk of myopathy, rhabdomyolysis, other adverse effects or decr. efficacy (BCRP-mediated transport inhibited, P-gp-mediated transport inhibited, hepatic metabolism induced)

  • sirolimus albumin-bound
  • Lumakras (sotorasib)
    +
    sirolimus albumin-bound
    1 interaction

    Avoid/Use Alternative

    sotorasib + sirolimus albumin-bound

    avoid combo: combo may incr. or decr. sirolimus albumin-bound levels, incr. risk of serious infection, myelosuppression, bleeding (including life-threatening), other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • sodium bicarbonate
  • Lumakras (sotorasib)
    +
    sodium bicarbonate
    1 interaction

    Avoid/Use Alternative

    sotorasib + sodium bicarbonate

    use alternative or give sotorasib 4h before or 10h after oral sodium bicarbonate: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • sodium citrate
  • Lumakras (sotorasib)
    +
    sodium citrate
    1 interaction

    Avoid/Use Alternative

    sotorasib + sodium citrate

    use alternative or give sotorasib 4h before or 10h after sodium citrate: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • sodium zirconium cyclosilicate
  • Lumakras (sotorasib)
    +
    sodium zirconium cyclosilicate
    1 interaction

    Avoid/Use Alternative

    sotorasib + sodium zirconium cyclosilicate

    use alternative or give sotorasib 4h before or 10h after sodium zirconium cyclosilicate: combo may decr. sotorasib levels, efficacy (absorption decreased at higher gastric pH)

  • sonidegib
  • Lumakras (sotorasib)
    +
    sonidegib
    1 interaction

    Avoid/Use Alternative

    sotorasib + sonidegib

    avoid combo: combo may decr. sonidegib levels, efficacy (hepatic metabolism induced)

  • St. John's wort
  • Lumakras (sotorasib)
    +
    St. John's wort
    1 interaction

    Avoid/Use Alternative

    sotorasib + St. John's wort

    avoid combo: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • sufentanil
  • Lumakras (sotorasib)
    +
    sufentanil
    1 interaction

    Avoid/Use Alternative

    sotorasib + sufentanil

    use alternative or consider sufentanil dose adjustment: combo may decr. sufentanil levels, efficacy (hepatic metabolism induced)

  • sunvozertinib
  • Lumakras (sotorasib)
    +
    sunvozertinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + sunvozertinib

    use alternative or incr. sunvozertinib dose to 400 mg once daily: combo may decr. sunvozertinib levels, efficacy (hepatic metabolism induced)

  • suzetrigine
  • Lumakras (sotorasib)
    +
    suzetrigine
    1 interaction

    Avoid/Use Alternative

    sotorasib + suzetrigine

    avoid combo: combo may decr. suzetrigine and active metabolite levels, efficacy (hepatic metabolism induced)

  • tadalafil
  • Lumakras (sotorasib)
    +
    tadalafil
    1 interaction

    Avoid/Use Alternative

    sotorasib + tadalafil

    PULMONARY HTN: consider alternative; ERECTILE DYSFUNCTION and BENIGN PROSTATIC HYPERPLASIA: caution advised: combo may decr. tadalafil levels, efficacy (hepatic metabolism induced)

  • taletrectinib
  • Lumakras (sotorasib)
    +
    taletrectinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + taletrectinib

    avoid combo: combo may decr. taletrectinib levels, efficacy (hepatic metabolism induced)

  • tamoxifen
  • Lumakras (sotorasib)
    +
    tamoxifen
    1 interaction

    Avoid/Use Alternative

    sotorasib + tamoxifen

    avoid combo: combo may decr. tamoxifen and active metabolite levels, efficacy (hepatic metabolism induced)

  • tasimelteon
  • Lumakras (sotorasib)
    +
    tasimelteon
    1 interaction

    Avoid/Use Alternative

    sotorasib + tasimelteon

    consider alternative: combo may decr. tasimelteon levels, efficacy (hepatic metabolism induced)

  • tazemetostat
  • Lumakras (sotorasib)
    +
    tazemetostat
    1 interaction

    Avoid/Use Alternative

    sotorasib + tazemetostat

    avoid combo: combo may decr. tazemetostat levels, efficacy (hepatic metabolism induced)

  • tezacaftor/ivacaftor
  • Lumakras (sotorasib)
    +
    tezacaftor/ ivacaftor
    1 interaction

    Avoid/Use Alternative

    sotorasib + tezacaftor/ ivacaftor

    avoid combo: combo may decr. tezacaftor/ivacaftor levels, efficacy (hepatic metabolism induced)

  • thiotepa
  • Lumakras (sotorasib)
    +
    thiotepa
    1 interaction

    Avoid/Use Alternative

    sotorasib + thiotepa

    use alternative or monitor CBC: combo may decr. thiotepa levels, efficacy; may incr. thiotepa active metabolite levels, risk of serious infection, myelosuppression, other adverse effects (hepatic metabolism induced, incr. metabolite formation)

  • ticagrelor
  • Lumakras (sotorasib)
    +
    ticagrelor
    1 interaction

    Avoid/Use Alternative

    sotorasib + ticagrelor

    avoid combo: combo may decr. ticagrelor levels, efficacy (hepatic metabolism induced)

  • tipranavir
  • Lumakras (sotorasib)
    +
    tipranavir
    1 interaction

    Avoid/Use Alternative

    sotorasib + tipranavir

    avoid combo: combo may decr. tipranavir levels, efficacy (hepatic metabolism induced)

  • tofacitinib
  • Lumakras (sotorasib)
    +
    tofacitinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + tofacitinib

    consider alternative: combo may decr. tofacitinib levels, efficacy (hepatic metabolism induced)

  • tolvaptan
  • Lumakras (sotorasib)
    +
    tolvaptan
    1 interaction

    Avoid/Use Alternative

    sotorasib + tolvaptan

    consider alternative: combo may decr. tolvaptan levels, efficacy (hepatic metabolism induced)

  • topotecan
  • Lumakras (sotorasib)
    +
    topotecan
    1 interaction

    Avoid/Use Alternative

    sotorasib + topotecan

    avoid combo w/ oral topotecan: combo may incr. topotecan levels, risk of serious infection, myelosuppression, other adverse effects (gut P-gp-mediated transport inhibited, gut BCRP-mediated transport inhibited)

  • toremifene
  • Lumakras (sotorasib)
    +
    toremifene
    1 interaction

    Avoid/Use Alternative

    sotorasib + toremifene

    consider alternative: combo may decr. toremifene levels, efficacy (hepatic metabolism induced)

  • tramadol
  • Lumakras (sotorasib)
    +
    tramadol
    1 interaction

    Avoid/Use Alternative

    sotorasib + tramadol

    use alternative or monitor withdrawal sx: combo may decr. tramadol levels, efficacy (hepatic metabolism induced)

  • ulipristal (post-coital contraceptive)
  • Lumakras (sotorasib)
    +
    ulipristal (post-coital contraceptive)
    1 interaction

    Avoid/Use Alternative

    sotorasib + ulipristal (post-coital contraceptive)

    avoid combo: combo may decr. ulipristal levels, post-coital contraceptive efficacy (hepatic metabolism induced)

  • valbenazine
  • Lumakras (sotorasib)
    +
    valbenazine
    1 interaction

    Avoid/Use Alternative

    sotorasib + valbenazine

    avoid combo: combo may decr. valbenazine levels. efficacy (hepatic metabolism induced)

  • vanzacaftor/tezacaftor/deutivacaftor
  • Lumakras (sotorasib)
    +
    vanzacaftor/ tezacaftor/ deutivacaftor
    1 interaction

    Avoid/Use Alternative

    sotorasib + vanzacaftor/ tezacaftor/ deutivacaftor

    avoid combo: combo may decr. vanzacaftor/tezacaftor/deutivacaftor levels, efficacy (hepatic metabolism induced)

  • velpatasvir
  • Lumakras (sotorasib)
    +
    velpatasvir
    1 interaction

    Avoid/Use Alternative

    sotorasib + velpatasvir

    avoid combo: combo may decr. velpatasvir levels, efficacy (hepatic metabolism induced)

  • venetoclax
  • Lumakras (sotorasib)
    +
    venetoclax
    1 interaction

    Avoid/Use Alternative

    sotorasib + venetoclax

    avoid combo: combo may incr. or decr. venetoclax levels, incr. risk of serious infection, myelosuppression, tumor lysis syndrome, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • verapamil
  • Lumakras (sotorasib)
    +
    verapamil
    1 interaction

    Avoid/Use Alternative

    sotorasib + verapamil

    use alternative: combo may decr. verapamil levels, efficacy (hepatic metabolism induced)

  • voclosporin
  • Lumakras (sotorasib)
    +
    voclosporin
    1 interaction

    Avoid/Use Alternative

    sotorasib + voclosporin

    avoid combo: combo may decr. voclosporin levels, efficacy (hepatic metabolism induced)

  • vonoprazan
  • Lumakras (sotorasib)
    +
    vonoprazan
    1 interaction

    Avoid/Use Alternative

    sotorasib + vonoprazan

    avoid combo: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced; absorption decreased at higher gastric pH)

  • voriconazole
  • Lumakras (sotorasib)
    +
    voriconazole
    1 interaction

    Avoid/Use Alternative

    sotorasib + voriconazole

    use alternative or monitor breakthrough fungal infection: combo may decr. voriconazole levels, efficacy (hepatic metabolism induced)

  • voxilaprevir
  • Lumakras (sotorasib)
    +
    voxilaprevir
    1 interaction

    Avoid/Use Alternative

    sotorasib + voxilaprevir

    avoid combo: combo may decr. voxilaprevir levels, efficacy (hepatic metabolism induced)

  • zanubrutinib
  • Lumakras (sotorasib)
    +
    zanubrutinib
    1 interaction

    Avoid/Use Alternative

    sotorasib + zanubrutinib

    use alternative or incr. zanubrutinib dose to 320 mg bid: combo may decr. zanubrutinib levels, efficacy (hepatic metabolism induced)

  • ziftomenib
  • Lumakras (sotorasib)
    +
    ziftomenib
    1 interaction

    Avoid/Use Alternative

    sotorasib + ziftomenib

    avoid combo: combo may decr. ziftomenib levels, efficacy (hepatic metabolism induced)

  • zuranolone
  • Lumakras (sotorasib)
    +
    zuranolone
    1 interaction

    Avoid/Use Alternative

    sotorasib + zuranolone

    avoid combo: combo may decr. zuranolone levels, efficacy (hepatic metabolism induced)

Monitor/Modify Tx

  • abiraterone acetate
  • Lumakras (sotorasib)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    sotorasib + abiraterone acetate

    if abiraterone coformulated w/ niraparib, caution advised; otherwise, consider abiraterone dose adjustment: combo may decr. abiraterone levels, efficacy (hepatic metabolism induced)

  • acalabrutinib
  • Lumakras (sotorasib)
    +
    acalabrutinib
    1 interaction

    Monitor/Modify Tx

    sotorasib + acalabrutinib

    consider acalabrutinib dose adjustment: combo may decr. acalabrutinib levels, efficacy (hepatic metabolism induced)

  • afatinib
  • Lumakras (sotorasib)
    +
    afatinib
    1 interaction

    Monitor/Modify Tx

    sotorasib + afatinib

    decr. afatinib dose by 10 mg/day if not tolerated: combo may incr. afatinib levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • aficamten
  • Lumakras (sotorasib)
    +
    aficamten
    1 interaction

    Monitor/Modify Tx

    sotorasib + aficamten

    monitor cardiac fxn, incl. LVEF; when discontinuing sotorasib, decr. aficamten dose as follows: if on aficamten 20 mg qd, decr. to 10 mg qd; if on aficamten 15 mg or 10 mg qd, decr. to 5 mg qd; if on aficamten 5 mg qd, continue 5 mg qd: combo may decr. aficamten levels, efficacy (hepatic metabolism induced)

  • aminophylline
  • Lumakras (sotorasib)
    +
    aminophylline
    1 interaction

    Monitor/Modify Tx

    sotorasib + aminophylline

    monitor theophylline levels: combo may decr. theophylline levels, efficacy (hepatic metabolism induced, aminophylline converted to theophylline)

  • amlodipine
  • Lumakras (sotorasib)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    sotorasib + amlodipine

    monitor BP: combo may decr. (lev)amlodipine levels, efficacy (hepatic metabolism induced)

  • apixaban
  • Lumakras (sotorasib)
    +
    apixaban
    1 interaction

    Monitor/Modify Tx

    sotorasib + apixaban

    monitor bleeding s/sx; if also combined w/ strong CYP3A4 inhibitor, consider apixaban dose adjustment: combo may incr. or decr. apixaban levels, incr. risk of bleeding, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • atorvastatin
  • Lumakras (sotorasib)
    +
    atorvastatin
    1 interaction

    Monitor/Modify Tx

    sotorasib + atorvastatin

    monitor CK, myopathy sx: combo may incr. or decr. atorvastatin levels, incr. risk of myopathy, rhabdomyolysis, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, BCRP-mediated transport inhibited, hepatic metabolism induced)

  • betamethasone
  • Lumakras (sotorasib)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    sotorasib + betamethasone

    consider betamethasone dose adjustment: combo may decr. betamethasone levels, efficacy (hepatic metabolism induced)

  • brexpiprazole
  • Lumakras (sotorasib)
    +
    brexpiprazole
    1 interaction

    Monitor/Modify Tx

    sotorasib + brexpiprazole

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • butorphanol
  • Lumakras (sotorasib)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    sotorasib + butorphanol

    monitor for withdrawal sx: combo may decr. butorphanol levels, efficacy (hepatic metabolism induced)

  • calcitriol
  • Lumakras (sotorasib)
    +
    calcitriol
    1 interaction

    Monitor/Modify Tx

    sotorasib + calcitriol

    monitor vitamin D levels: combo may decr. vitamin D levels, efficacy (hepatic metabolism induced)

  • carvedilol
  • Lumakras (sotorasib)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    sotorasib + carvedilol

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • cholecalciferol (vitamin D3)
  • Lumakras (sotorasib)
    +
    cholecalciferol (vitamin D3)
    1 interaction

    Monitor/Modify Tx

    sotorasib + cholecalciferol (vitamin D3)

    monitor vitamin D levels: combo may decr. vitamin D levels, efficacy (hepatic metabolism induced)

  • clozapine
  • Lumakras (sotorasib)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    sotorasib + clozapine

    consider incr. clozapine dose: combo may decr. clozapine levels, efficacy (hepatic metabolism induced)

  • crinecerfont
  • Lumakras (sotorasib)
    +
    crinecerfont
    1 interaction

    Monitor/Modify Tx

    sotorasib + crinecerfont

    ADULTS: keep 100 mg morning dose unchanged, incr. crinecerfont evening dose to 200 mg; PEDS 4 YO AND OLDER: incr. crinecerfont dose based on weight as follows: if 10-19 kg, keep 25 mg morning dose unchanged, incr. crinecerfont evening dose to 50 mg; if 20-54 kg, keep 50 mg morning dose unchanged, incr. crinecerfont evening dose to 100 mg; if 55 kg or greater, keep 100 mg morning dose unchanged, incr. crinecerfont evening dose to 200 mg: combo may decr. crinecerfont levels, efficacy (hepatic metabolism induced)

  • cyclophosphamide
  • Lumakras (sotorasib)
    +
    cyclophosphamide
    1 interaction

    Monitor/Modify Tx

    sotorasib + cyclophosphamide

    monitor CBC, renal, cardiac fxn: combo may incr. cyclophosphamide active metabolite levels, risk of serious infection, myelosuppression, nephrotoxicity, cardiotoxicity, other adverse effects (hepatic metabolism possibly induced, incr. active metabolite formation)

  • cyclosporine
  • Lumakras (sotorasib)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    sotorasib + cyclosporine

    monitor cyclosporine levels, renal fxn: combo may incr. or decr. cyclosporine levels, incr. risk of serious infection, nephrotoxicity, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • digoxin
  • Lumakras (sotorasib)
    +
    digoxin
    1 interaction

    Monitor/Modify Tx

    sotorasib + digoxin

    monitor digoxin levels, HR; decr. digoxin frequency or dose by 15-30%: combo may incr. digoxin levels, risk of bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • disopyramide
  • Lumakras (sotorasib)
    +
    disopyramide
    1 interaction

    Monitor/Modify Tx

    sotorasib + disopyramide

    monitor disopyramide levels: combo may decr. disopyramide levels, efficacy (hepatic metabolism induced)

  • doxercalciferol
  • Lumakras (sotorasib)
    +
    doxercalciferol
    1 interaction

    Monitor/Modify Tx

    sotorasib + doxercalciferol

    monitor calcium, iPTH: combo may alter doxercalciferol and active metabolite levels, efficacy (hepatic metabolism induced, net effect on vitamin D activation/inactivation unknown)

  • edoxaban
  • Lumakras (sotorasib)
    +
    edoxaban
    1 interaction

    Monitor/Modify Tx

    sotorasib + edoxaban

    monitor bleeding s/sx; decr. edoxaban dose to 30 mg/day in DVT/PE pts; no dose adjustment recommended in atrial fibrillation pts: combo may incr. edoxaban levels, risk of bleeding, other adverse effects (P-gp-mediated transport inhibited)

  • enfortumab vedotin
  • Lumakras (sotorasib)
    +
    enfortumab vedotin
    1 interaction

    Monitor/Modify Tx

    sotorasib + enfortumab vedotin

    if also combined w/ strong CYP3A4 inhibitor, monitor CBC, glucose; otherwise, caution advised: combo may incr. or decr. enfortumab vedotin levels, incr. risk of myelosuppression, neuropathy, hyperglycemia, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • ethosuximide
  • Lumakras (sotorasib)
    +
    ethosuximide
    1 interaction

    Monitor/Modify Tx

    sotorasib + ethosuximide

    monitor ethosuximide levels: combo may decr. ethosuximide levels, efficacy (hepatic metabolism induced)

  • fexinidazole
  • Lumakras (sotorasib)
    +
    fexinidazole
    1 interaction

    Monitor/Modify Tx

    sotorasib + fexinidazole

    monitor ECG: combo may incr. fexinidazole active metabolite levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects; may decr. sotorasib levels, efficacy (hepatic metabolism induced, incr. conversion to active metabolites)

  • fludrocortisone
  • Lumakras (sotorasib)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    sotorasib + fludrocortisone

    consider fludrocortisone dose adjustment: combo may decr. fludrocortisone levels, efficacy (hepatic metabolism induced)

  • fluvastatin
  • Lumakras (sotorasib)
    +
    fluvastatin
    1 interaction

    Monitor/Modify Tx

    sotorasib + fluvastatin

    monitor CK, myopathy sx: combo may incr. fluvastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (BCRP-mediated transport inhibited)

  • guanfacine
  • Lumakras (sotorasib)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    sotorasib + guanfacine

    consider incr. guanfacine ER dose up to double, consider incr. dose for immed.-release form: combo may decr. guanfacine levels, efficacy (hepatic metabolism induced)

  • haloperidol
  • Lumakras (sotorasib)
    +
    haloperidol
    1 interaction

    Monitor/Modify Tx

    sotorasib + haloperidol

    consider haloperidol dose adjustment: combo may decr. haloperidol levels, efficacy (hepatic metabolism induced)

  • hydrocortisone
  • Lumakras (sotorasib)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    sotorasib + hydrocortisone

    consider hydrocortisone dose adjustment: combo may decr. hydrocortisone levels, efficacy (hepatic metabolism induced)

  • ifosfamide
  • Lumakras (sotorasib)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    sotorasib + ifosfamide

    monitor CBC, renal, cardiac fxn; consider ifosfamide dose adjustment: combo may incr. ifosfamide active and toxic metabolite levels, risk of myelosuppression, serious infection, encephalopathy, nephrotoxicity, cardiotoxicity, other adverse effects (hepatic metabolism induced, incr. metabolite formation)

  • imipramine
  • Lumakras (sotorasib)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    sotorasib + imipramine

    monitor imipramine levels: combo may decr. imipramine levels, efficacy (hepatic metabolism induced)

  • lapatinib
  • Lumakras (sotorasib)
    +
    lapatinib
    1 interaction

    Monitor/Modify Tx

    sotorasib + lapatinib

    monitor ECG; consider lapatinib dose adjustment: combo may incr. or decr. lapatinib levels, incr. risk of QT prolongation, cardiac arrhythmias, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, BCRP-mediated transport inhibited, hepatic metabolism induced)

  • lovastatin
  • Lumakras (sotorasib)
    +
    lovastatin
    1 interaction

    Monitor/Modify Tx

    sotorasib + lovastatin

    monitor CK, myopathy sx: combo may incr. or decr. lovastatin levels, incr. risk of myopathy, rhabdomyolysis, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • lurasidone
  • Lumakras (sotorasib)
    +
    lurasidone
    1 interaction

    Monitor/Modify Tx

    sotorasib + lurasidone

    consider lurasidone dose adjustment: combo may decr. lurasidone levels, efficacy (hepatic metabolism induced)

  • macimorelin
  • Lumakras (sotorasib)
    +
    macimorelin
    1 interaction

    Monitor/Modify Tx

    sotorasib + macimorelin

    D/C sotorasib, allowing sufficient washout time before diagnostic test: combo may decr. macimorelin levels, result in false positive test (hepatic metabolism induced)

  • mavorixafor
  • Lumakras (sotorasib)
    +
    mavorixafor
    1 interaction

    Monitor/Modify Tx

    sotorasib + mavorixafor

    monitor ECG: combo may incr. or decr. mavorixafor levels, incr. risk of QT prolongation, cardiac arrhythmias, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • methotrexate
  • Lumakras (sotorasib)
    +
    methotrexate
    1 interaction

    Monitor/Modify Tx

    sotorasib + methotrexate

    monitor CBC, renal fxn: combo may incr. methotrexate levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (BCRP-mediated transport inhibited)

  • mitoxantrone
  • Lumakras (sotorasib)
    +
    mitoxantrone
    1 interaction

    Monitor/Modify Tx

    sotorasib + mitoxantrone

    monitor CBC, cardiac fxn, incl. LVEF: combo may incr. mitoxantrone levels, risk of serious infection, myelosuppression, cardiotoxicity, other adverse effects (BCRP-mediated transport inhibited)

  • morphine
  • Lumakras (sotorasib)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    sotorasib + morphine

    monitor respiratory rate; consider decr. dose of one or both drugs: combo may incr. morphine levels, risk of CNS and respiratory depression, psychomotor impairment, other adverse effects (P-gp-mediated transport inhibited)

  • nimodipine
  • Lumakras (sotorasib)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    sotorasib + nimodipine

    monitor BP: combo may decr. nimodipine levels, efficacy (hepatic metabolism induced)

  • nortriptyline
  • Lumakras (sotorasib)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    sotorasib + nortriptyline

    monitor nortriptyline levels: combo may decr. nortriptyline levels, efficacy (hepatic metabolism induced)

  • orforglipron
  • Lumakras (sotorasib)
    +
    orforglipron
    1 interaction

    Monitor/Modify Tx

    sotorasib + orforglipron

    consider orforglipron dose adjustment: combo may decr. orforglipron levels, efficacy (hepatic metabolism induced)

  • paltusotine
  • Lumakras (sotorasib)
    +
    paltusotine
    1 interaction

    Monitor/Modify Tx

    sotorasib + paltusotine

    may incr. usual paltusotine dose up to 2-fold, not to exceed 120 mg daily: combo may decr. paltusotine levels, efficacy (hepatic metabolism induced)

  • perampanel
  • Lumakras (sotorasib)
    +
    perampanel
    1 interaction

    Monitor/Modify Tx

    sotorasib + perampanel

    incr. perampanel start dose to 4 mg/day: combo may decr. perampanel levels, efficacy (hepatic metabolism induced)

  • pitavastatin
  • Lumakras (sotorasib)
    +
    pitavastatin
    1 interaction

    Monitor/Modify Tx

    sotorasib + pitavastatin

    monitor CK, myopathy sx: combo may incr. pitavastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (BCRP-mediated transport inhibited, P-gp-mediated transport inhibited)

  • pravastatin
  • Lumakras (sotorasib)
    +
    pravastatin
    1 interaction

    Monitor/Modify Tx

    sotorasib + pravastatin

    monitor CK, myopathy sx: combo may incr. pravastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (BCRP-mediated transport inhibited)

  • quetiapine
  • Lumakras (sotorasib)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    sotorasib + quetiapine

    consider quetiapine dose adjustment: combo may decr. quetiapine levels, efficacy (hepatic metabolism induced)

  • quinidine (antiarrhythmic)
  • Lumakras (sotorasib)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Monitor/Modify Tx

    sotorasib + quinidine (antiarrhythmic)

    monitor quinidine levels, ECG: combo may incr. or decr. quinidine levels, incr. risk of QT prolongation, cardiac arrhythmias, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • quinidine (CYP2D6 inhibitor)
  • Lumakras (sotorasib)
    +
    quinidine (CYP2D6 inhibitor)
    1 interaction

    Monitor/Modify Tx

    sotorasib + quinidine (CYP2D6 inhibitor)

    monitor ECG: combo may incr. or decr. quinidine levels, incr. risk of QT prolongation, cardiac arrhythmias, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • red yeast rice
  • Lumakras (sotorasib)
    +
    red yeast rice
    1 interaction

    Monitor/Modify Tx

    sotorasib + red yeast rice

    monitor CK, myopathy sx w/ large amounts of red yeast rice: combo may incr. lovastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (P-gp-mediated transport inhibited, red yeast rice contains varying amounts of lovastatin)

  • repaglinide
  • Lumakras (sotorasib)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    sotorasib + repaglinide

    monitor glucose: combo may decr. repaglinide levels, efficacy (hepatic metabolism induced)

  • riociguat
  • Lumakras (sotorasib)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    sotorasib + riociguat

    consider decr. riociguat start dose to 0.5 mg PO tid; monitor BP: combo may incr. riociguat levels, risk of severe hypotension, other adverse effects (P-gp-mediated transport inhibited, BCRP-mediated transport inhibited)

  • rosuvastatin
  • Lumakras (sotorasib)
    +
    rosuvastatin
    1 interaction

    Monitor/Modify Tx

    sotorasib + rosuvastatin

    monitor CK, myopathy sx: combo may incr. rosuvastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (BCRP-mediated transport inhibited)

  • sildenafil
  • Lumakras (sotorasib)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    sotorasib + sildenafil

    PULMONARY HTN: consider sildenafil dose adjustment; ERECTILE DYSFUNCTION: caution advised: combo may decr. sildenafil levels, efficacy (hepatic metabolism induced)

  • sirolimus
  • Lumakras (sotorasib)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    sotorasib + sirolimus

    monitor sirolimus levels: combo may incr. or decr. sirolimus levels, incr. risk of serious infection, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • stiripentol
  • Lumakras (sotorasib)
    +
    stiripentol
    1 interaction

    Monitor/Modify Tx

    sotorasib + stiripentol

    consider stiripentol dose adjustment: combo may decr. stiripentol levels, efficacy (hepatic metabolism possibly induced)

  • tacrolimus
  • Lumakras (sotorasib)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    sotorasib + tacrolimus

    monitor tacrolimus levels, ECG, renal fxn: combo may incr. or decr. tacrolimus levels, incr. risk of QT prolongation, cardiac arrhythmias, nephrotoxicity, other adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • talazoparib
  • Lumakras (sotorasib)
    +
    talazoparib
    1 interaction

    Monitor/Modify Tx

    sotorasib + talazoparib

    monitor CBC: combo may incr. talazoparib levels, risk of myelosuppression, other adverse effects (P-gp-mediated transport inhibited, BCRP-mediated transport inhibited)

  • temsirolimus
  • Lumakras (sotorasib)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    sotorasib + temsirolimus

    consider temsirolimus dose adjustment: combo may decr. temsirolimus and active metabolite sirolimus levels, efficacy (hepatic metabolism induced)

  • tenofovir alafenamide
  • Lumakras (sotorasib)
    +
    tenofovir alafenamide
    1 interaction

    Monitor/Modify Tx

    sotorasib + tenofovir alafenamide

    if tenofovir alafenamide not admin. w/ cobicistat, monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (gut P-gp-mediated transport inhibited, gut BCRP-mediated transport inhibited)

  • tenofovir disoproxil
  • Lumakras (sotorasib)
    +
    tenofovir disoproxil
    1 interaction

    Monitor/Modify Tx

    sotorasib + tenofovir disoproxil

    monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (gut P-gp-mediated transport inhibited, gut BCRP-mediated transport inhibited)

  • theophylline
  • Lumakras (sotorasib)
    +
    theophylline
    1 interaction

    Monitor/Modify Tx

    sotorasib + theophylline

    monitor theophylline levels: combo may decr. theophylline levels, efficacy (hepatic metabolism induced)

  • tiagabine
  • Lumakras (sotorasib)
    +
    tiagabine
    1 interaction

    Monitor/Modify Tx

    sotorasib + tiagabine

    consider tiagabine dose adjustment if not on concurrent enzyme-inducing AEDs; titrate tiagabine dose to effect if already on enzyme-inducing AEDs: combo may decr. tiagabine levels, efficacy (hepatic metabolism induced; further induction possible if on concurrent enzyme-inducing AEDs)

  • ubrogepant
  • Lumakras (sotorasib)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    sotorasib + ubrogepant

    consider ubrogepant dose adjustment: combo may incr. or decr. ubrogepant levels, incr. risk of adverse effects or decr. efficacy (P-gp-mediated transport inhibited, BCRP-mediated transport inhibited, hepatic metabolism induced)

  • vilazodone
  • Lumakras (sotorasib)
    +
    vilazodone
    1 interaction

    Monitor/Modify Tx

    sotorasib + vilazodone

    consider vilazodone dose adjustment: combo may decr. vilazodone levels, efficacy (hepatic metabolism induced)

  • vortioxetine
  • Lumakras (sotorasib)
    +
    vortioxetine
    1 interaction

    Monitor/Modify Tx

    sotorasib + vortioxetine

    consider vortioxetine dose adjustment: combo may decr. vortioxetine levels, efficacy (hepatic metabolism induced)

  • warfarin
  • Lumakras (sotorasib)
    +
    warfarin
    1 interaction

    Monitor/Modify Tx

    sotorasib + warfarin

    monitor INR: combo may decr. warfarin levels, efficacy (hepatic metabolism induced)

  • zonisamide
  • Lumakras (sotorasib)
    +
    zonisamide
    1 interaction

    Monitor/Modify Tx

    sotorasib + zonisamide

    consider zonisamide dose adjustment: combo may decr. zonisamide levels, efficacy (hepatic metabolism induced)

Caution Advised

  • adagrasib
  • Lumakras (sotorasib)
    +
    adagrasib
    1 interaction

    Caution Advised

    sotorasib + adagrasib

    caution advised: combo may decr. adagrasib levels, efficacy (hepatic metabolism induced)

  • albendazole
  • Lumakras (sotorasib)
    +
    albendazole
    1 interaction

    Caution Advised

    sotorasib + albendazole

    caution advised: combo may decr. albendazole levels, efficacy (hepatic metabolism induced)

  • aliskiren
  • Lumakras (sotorasib)
    +
    aliskiren
    1 interaction

    Caution Advised

    sotorasib + aliskiren

    caution advised: combo may incr. or decr. aliskiren levels, incr. risk of adverse effects or decr. efficacy (P-gp-mediated transport inhibited, hepatic metabolism induced)

  • alprazolam
  • Lumakras (sotorasib)
    +
    alprazolam
    1 interaction

    Caution Advised

    sotorasib + alprazolam

    caution advised: combo may decr. alprazolam levels, efficacy (hepatic metabolism induced)

  • amiodarone
  • Lumakras (sotorasib)
    +
    amiodarone
    1 interaction

    Caution Advised

    sotorasib + amiodarone

    caution advised: combo may decr. amiodarone levels, efficacy (hepatic metabolism induced)

  • apremilast
  • Lumakras (sotorasib)
    +
    apremilast
    1 interaction

    Caution Advised

    sotorasib + apremilast

    caution advised: combo may decr. apremilast levels, efficacy (hepatic metabolism induced)

  • aripiprazole bimonthly injection
  • Lumakras (sotorasib)
    +
    aripiprazole bimonthly injection
    1 interaction

    Caution Advised

    sotorasib + aripiprazole bimonthly injection

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • aripiprazole lauroxil
  • Lumakras (sotorasib)
    +
    aripiprazole lauroxil
    1 interaction

    Caution Advised

    sotorasib + aripiprazole lauroxil

    caution advised, especially if aripiprazole lauroxil 441 mg qmo: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • aripiprazole monthly injection
  • Lumakras (sotorasib)
    +
    aripiprazole monthly injection
    1 interaction

    Caution Advised

    sotorasib + aripiprazole monthly injection

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • aripiprazole oral
  • Lumakras (sotorasib)
    +
    aripiprazole oral
    1 interaction

    Caution Advised

    sotorasib + aripiprazole oral

    caution advised if concurrent use >14 days: combo may decr. aripiprazole levels, efficacy (hepatic metabolism induced)

  • avanafil
  • Lumakras (sotorasib)
    +
    avanafil
    1 interaction

    Caution Advised

    sotorasib + avanafil

    caution advised: combo may decr. avanafil levels, efficacy (hepatic metabolism induced)

  • belumosudil
  • Lumakras (sotorasib)
    +
    belumosudil
    1 interaction

    Caution Advised

    sotorasib + belumosudil

    caution advised: combo may decr. belumosudil levels, efficacy (hepatic metabolism induced)

  • bortezomib
  • Lumakras (sotorasib)
    +
    bortezomib
    1 interaction

    Caution Advised

    sotorasib + bortezomib

    caution advised: combo may decr. bortezomib levels, efficacy (hepatic metabolism induced)

  • bosentan
  • Lumakras (sotorasib)
    +
    bosentan
    1 interaction

    Caution Advised

    sotorasib + bosentan

    caution advised: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • budesonide
  • Lumakras (sotorasib)
    +
    budesonide
    1 interaction

    Caution Advised

    sotorasib + budesonide

    caution advised: combo may decr. budesonide levels, efficacy (hepatic metabolism induced)

  • cannabis
  • Lumakras (sotorasib)
    +
    cannabis
    1 interaction

    Caution Advised

    sotorasib + cannabis

    caution advised: combo may decr. cannabis levels, efficacy (hepatic metabolism induced)

  • cenobamate
  • Lumakras (sotorasib)
    +
    cenobamate
    1 interaction

    Caution Advised

    sotorasib + cenobamate

    caution advised: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • ceritinib
  • Lumakras (sotorasib)
    +
    ceritinib
    1 interaction

    Caution Advised

    sotorasib + ceritinib

    caution advised: combo may decr. ceritinib levels, efficacy (hepatic metabolism induced)

  • clindamycin
  • Lumakras (sotorasib)
    +
    clindamycin
    1 interaction

    Caution Advised

    sotorasib + clindamycin

    caution advised: combo may decr. clindamycin levels, efficacy (hepatic metabolism induced)

  • copanlisib
  • Lumakras (sotorasib)
    +
    copanlisib
    1 interaction

    Caution Advised

    sotorasib + copanlisib

    caution advised: combo may decr. copanlisib levels, efficacy (hepatic metabolism induced)

  • cortisone
  • Lumakras (sotorasib)
    +
    cortisone
    1 interaction

    Caution Advised

    sotorasib + cortisone

    caution advised: combo may decr. cortisone levels, efficacy (hepatic metabolism induced)

  • dabrafenib
  • Lumakras (sotorasib)
    +
    dabrafenib
    1 interaction

    Caution Advised

    sotorasib + dabrafenib

    caution advised: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • dapsone
  • Lumakras (sotorasib)
    +
    dapsone
    1 interaction

    Caution Advised

    sotorasib + dapsone

    caution advised: combo may decr. dapsone levels, incr. toxic metabolite levels, risk of hematologic adverse effects or decr. efficacy (hepatic metabolism induced, incr. toxic metabolite formation)

  • darunavir
  • Lumakras (sotorasib)
    +
    darunavir
    1 interaction

    Caution Advised

    sotorasib + darunavir

    caution advised: combo may decr. darunavir levels, efficacy (hepatic metabolism induced)

  • dasatinib
  • Lumakras (sotorasib)
    +
    dasatinib
    1 interaction

    Caution Advised

    sotorasib + dasatinib

    caution advised: combo may decr. dasatinib levels, efficacy (hepatic metabolism induced)

  • dexamethasone
  • Lumakras (sotorasib)
    +
    dexamethasone
    1 interaction

    Caution Advised

    sotorasib + dexamethasone

    caution advised: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • diazepam
  • Lumakras (sotorasib)
    +
    diazepam
    1 interaction

    Caution Advised

    sotorasib + diazepam

    caution advised: combo may decr. diazepam levels, efficacy (hepatic metabolism induced)

  • drospirenone (hormone replacement)
  • Lumakras (sotorasib)
    +
    drospirenone (hormone replacement)
    1 interaction

    Caution Advised

    sotorasib + drospirenone (hormone replacement)

    caution advised: combo may decr. drospirenone levels, efficacy (hepatic metabolism induced)

  • efavirenz
  • Lumakras (sotorasib)
    +
    efavirenz
    1 interaction

    Caution Advised

    sotorasib + efavirenz

    caution advised: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • eliglustat
  • Lumakras (sotorasib)
    +
    eliglustat
    1 interaction

    Caution Advised

    sotorasib + eliglustat

    caution advised: combo may decr. eliglustat levels, efficacy (hepatic metabolism induced)

  • erythromycin
  • Lumakras (sotorasib)
    +
    erythromycin
    1 interaction

    Caution Advised

    sotorasib + erythromycin

    caution advised: combo may decr. erythromycin levels, efficacy (hepatic metabolism induced)

  • eszopiclone
  • Lumakras (sotorasib)
    +
    eszopiclone
    1 interaction

    Caution Advised

    sotorasib + eszopiclone

    caution advised: combo may decr. eszopiclone levels, efficacy (hepatic metabolism induced)

  • ethinyl estradiol (hormone replacement)
  • Lumakras (sotorasib)
    +
    ethinyl estradiol (hormone replacement)
    1 interaction

    Caution Advised

    sotorasib + ethinyl estradiol (hormone replacement)

    caution advised: combo may decr. ethinyl estradiol levels, efficacy (hepatic metabolism induced)

  • etoposide
  • Lumakras (sotorasib)
    +
    etoposide
    1 interaction

    Caution Advised

    sotorasib + etoposide

    caution advised: combo may decr. etoposide levels, efficacy (hepatic metabolism induced)

  • etrasimod
  • Lumakras (sotorasib)
    +
    etrasimod
    1 interaction

    Caution Advised

    sotorasib + etrasimod

    caution advised: combo may decr. etrasimod levels, efficacy (hepatic metabolism induced)

  • etravirine
  • Lumakras (sotorasib)
    +
    etravirine
    1 interaction

    Caution Advised

    sotorasib + etravirine

    caution advised: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • exemestane
  • Lumakras (sotorasib)
    +
    exemestane
    1 interaction

    Caution Advised

    sotorasib + exemestane

    caution advised: combo may decr. exemestane levels, efficacy (hepatic metabolism induced)

  • felbamate
  • Lumakras (sotorasib)
    +
    felbamate
    1 interaction

    Caution Advised

    sotorasib + felbamate

    caution advised: combo may decr. felbamate levels, efficacy (hepatic metabolism induced)

  • fenfluramine
  • Lumakras (sotorasib)
    +
    fenfluramine
    1 interaction

    Caution Advised

    sotorasib + fenfluramine

    caution advised: combo may decr. fenfluramine levels, efficacy (hepatic metabolism induced)

  • fesoterodine
  • Lumakras (sotorasib)
    +
    fesoterodine
    1 interaction

    Caution Advised

    sotorasib + fesoterodine

    caution advised: combo may decr. fesoterodine active metabolite levels, efficacy (hepatic metabolism induced)

  • finasteride
  • Lumakras (sotorasib)
    +
    finasteride
    1 interaction

    Caution Advised

    sotorasib + finasteride

    caution advised: combo may decr. finasteride levels, efficacy (hepatic metabolism induced)

  • flibanserin
  • Lumakras (sotorasib)
    +
    flibanserin
    1 interaction

    Caution Advised

    sotorasib + flibanserin

    caution advised: combo may decr. flibanserin levels, efficacy (hepatic metabolism induced)

  • fostemsavir
  • Lumakras (sotorasib)
    +
    fostemsavir
    1 interaction

    Caution Advised

    sotorasib + fostemsavir

    caution advised: combo may decr. temsavir levels, efficacy (hepatic metabolism induced)

  • futibatinib
  • Lumakras (sotorasib)
    +
    futibatinib
    1 interaction

    Caution Advised

    sotorasib + futibatinib

    caution advised: combo may decr. futibatinib levels, efficacy (hepatic metabolism induced)

  • gefitinib
  • Lumakras (sotorasib)
    +
    gefitinib
    1 interaction

    Caution Advised

    sotorasib + gefitinib

    caution advised: combo may decr. gefitinib levels, efficacy (hepatic metabolism induced)

  • gepirone
  • Lumakras (sotorasib)
    +
    gepirone
    1 interaction

    Caution Advised

    sotorasib + gepirone

    caution advised: combo may decr. gepirone levels, efficacy (hepatic metabolism induced)

  • glyburide
  • Lumakras (sotorasib)
    +
    glyburide
    1 interaction

    Caution Advised

    sotorasib + glyburide

    caution advised: combo may decr. glyburide levels, efficacy (hepatic metabolism induced)

  • imlunestrant
  • Lumakras (sotorasib)
    +
    imlunestrant
    1 interaction

    Caution Advised

    sotorasib + imlunestrant

    caution advised: combo may decr. imlunestrant levels, efficacy (hepatic metabolism induced)

  • isotretinoin
  • Lumakras (sotorasib)
    +
    isotretinoin
    1 interaction

    Caution Advised

    sotorasib + isotretinoin

    caution advised: combo may decr. isotretinoin levels, efficacy (hepatic metabolism induced)

  • ivabradine
  • Lumakras (sotorasib)
    +
    ivabradine
    1 interaction

    Caution Advised

    sotorasib + ivabradine

    caution advised: combo may decr. ivabradine levels, efficacy (hepatic metabolism induced)

  • ixabepilone
  • Lumakras (sotorasib)
    +
    ixabepilone
    1 interaction

    Caution Advised

    sotorasib + ixabepilone

    caution advised: combo may decr. ixabepilone levels, efficacy (hepatic metabolism induced)

  • ixazomib
  • Lumakras (sotorasib)
    +
    ixazomib
    1 interaction

    Caution Advised

    sotorasib + ixazomib

    caution advised: combo may decr. ixazomib levels, efficacy (hepatic metabolism induced)

  • levonorgestrel (hormone replacement)
  • Lumakras (sotorasib)
    +
    levonorgestrel (hormone replacement)
    1 interaction

    Caution Advised

    sotorasib + levonorgestrel (hormone replacement)

    caution advised: combo may decr. levonorgestrel levels, efficacy (hepatic metabolism induced)

  • levonorgestrel intrauterine device (contraceptive)
  • Lumakras (sotorasib)
    +
    levonorgestrel intrauterine device (contraceptive)
    1 interaction

    Caution Advised

    sotorasib + levonorgestrel intrauterine device (contraceptive)

    caution advised: combo may decr. levonorgestrel levels, contraceptive efficacy (hepatic metabolism possibly induced)

  • maribavir
  • Lumakras (sotorasib)
    +
    maribavir
    1 interaction

    Caution Advised

    sotorasib + maribavir

    caution advised: combo may decr. maribavir levels, efficacy (hepatic metabolism induced)

  • mefloquine
  • Lumakras (sotorasib)
    +
    mefloquine
    1 interaction

    Caution Advised

    sotorasib + mefloquine

    caution advised: combo may decr. mefloquine levels, efficacy (hepatic metabolism induced)

  • methylprednisolone
  • Lumakras (sotorasib)
    +
    methylprednisolone
    1 interaction

    Caution Advised

    sotorasib + methylprednisolone

    caution advised: combo may decr. methylprednisolone levels, efficacy (hepatic metabolism induced)

  • metoclopramide
  • Lumakras (sotorasib)
    +
    metoclopramide
    1 interaction

    Caution Advised

    sotorasib + metoclopramide

    caution advised: combo may decr. metoclopramide levels, efficacy (hepatic metabolism induced)

  • modafinil
  • Lumakras (sotorasib)
    +
    modafinil
    1 interaction

    Caution Advised

    sotorasib + modafinil

    caution advised: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • nafcillin
  • Lumakras (sotorasib)
    +
    nafcillin
    1 interaction

    Caution Advised

    sotorasib + nafcillin

    caution advised: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • nintedanib
  • Lumakras (sotorasib)
    +
    nintedanib
    1 interaction

    Caution Advised

    sotorasib + nintedanib

    caution advised: combo may decr. nintedanib levels, efficacy (hepatic metabolism induced)

  • norethindrone (hormone replacement)
  • Lumakras (sotorasib)
    +
    norethindrone (hormone replacement)
    1 interaction

    Caution Advised

    sotorasib + norethindrone (hormone replacement)

    caution advised: combo may decr. norethindrone levels, efficacy (hepatic metabolism induced)

  • ondansetron
  • Lumakras (sotorasib)
    +
    ondansetron
    1 interaction

    Caution Advised

    sotorasib + ondansetron

    caution advised: combo may decr. ondansetron levels, efficacy (hepatic metabolism induced)

  • osimertinib
  • Lumakras (sotorasib)
    +
    osimertinib
    1 interaction

    Caution Advised

    sotorasib + osimertinib

    caution advised: combo may decr. osimertinib levels, efficacy (hepatic metabolism induced)

  • oxcarbazepine
  • Lumakras (sotorasib)
    +
    oxcarbazepine
    1 interaction

    Caution Advised

    sotorasib + oxcarbazepine

    caution advised: combo may decr. oxcarbazepine active metabolite levels, efficacy (hepatic metabolism induced)

  • paclitaxel
  • Lumakras (sotorasib)
    +
    paclitaxel
    1 interaction

    Caution Advised

    sotorasib + paclitaxel

    caution advised: combo may decr. paclitaxel levels, efficacy (hepatic metabolism induced)

  • pacritinib
  • Lumakras (sotorasib)
    +
    pacritinib
    1 interaction

    Caution Advised

    sotorasib + pacritinib

    caution advised: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • pexidartinib
  • Lumakras (sotorasib)
    +
    pexidartinib
    1 interaction

    Caution Advised

    sotorasib + pexidartinib

    caution advised: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • pibrentasvir
  • Lumakras (sotorasib)
    +
    pibrentasvir
    1 interaction

    Caution Advised

    sotorasib + pibrentasvir

    caution advised: combo may incr. pibrentasvir levels, risk of adverse effects (P-gp-mediated transport inhibited, BCRP-mediated transport inhibited)

  • pitolisant
  • Lumakras (sotorasib)
    +
    pitolisant
    1 interaction

    Caution Advised

    sotorasib + pitolisant

    caution advised: combo may decr. pitolisant levels, efficacy (hepatic metabolism induced)

  • polatuzumab vedotin
  • Lumakras (sotorasib)
    +
    polatuzumab vedotin
    1 interaction

    Caution Advised

    sotorasib + polatuzumab vedotin

    caution advised: combo may decr. polatuzumab vedotin levels, efficacy (hepatic metabolism induced)

  • prednisolone
  • Lumakras (sotorasib)
    +
    prednisolone
    1 interaction

    Caution Advised

    sotorasib + prednisolone

    caution advised: combo may decr. prednisolone levels, efficacy (hepatic metabolism induced)

  • prednisone
  • Lumakras (sotorasib)
    +
    prednisone
    1 interaction

    Caution Advised

    sotorasib + prednisone

    caution advised: combo may decr. prednisone levels, efficacy (hepatic metabolism induced)

  • progesterone (hormone replacement)
  • Lumakras (sotorasib)
    +
    progesterone (hormone replacement)
    1 interaction

    Caution Advised

    sotorasib + progesterone (hormone replacement)

    caution advised: combo may decr. progesterone levels, efficacy (hepatic metabolism induced)

  • progesterone vaginal (hormone replacement)
  • Lumakras (sotorasib)
    +
    progesterone vaginal (hormone replacement)
    1 interaction

    Caution Advised

    sotorasib + progesterone vaginal (hormone replacement)

    caution advised: combo may decr. progesterone levels, efficacy (hepatic metabolism induced)

  • propafenone
  • Lumakras (sotorasib)
    +
    propafenone
    1 interaction

    Caution Advised

    sotorasib + propafenone

    caution advised: combo may decr. propafenone levels, efficacy (hepatic metabolism induced)

  • quinine
  • Lumakras (sotorasib)
    +
    quinine
    1 interaction

    Caution Advised

    sotorasib + quinine

    caution advised: combo may decr. quinine levels, efficacy (hepatic metabolism induced)

  • ramelteon
  • Lumakras (sotorasib)
    +
    ramelteon
    1 interaction

    Caution Advised

    sotorasib + ramelteon

    caution advised: combo may decr. ramelteon levels, efficacy (hepatic metabolism induced)

  • regorafenib
  • Lumakras (sotorasib)
    +
    regorafenib
    1 interaction

    Caution Advised

    sotorasib + regorafenib

    caution advised: combo may decr. regorafenib levels, efficacy (hepatic metabolism induced)

  • relacorilant
  • Lumakras (sotorasib)
    +
    relacorilant
    1 interaction

    Caution Advised

    sotorasib + relacorilant

    caution advised: combo may decr. relacorilant levels, efficacy (hepatic metabolism possibly induced)

  • rifapentine
  • Lumakras (sotorasib)
    +
    rifapentine
    1 interaction

    Caution Advised

    sotorasib + rifapentine

    caution advised: combo may decr. sotorasib levels, efficacy (hepatic metabolism induced)

  • risperidone
  • Lumakras (sotorasib)
    +
    risperidone
    1 interaction

    Caution Advised

    sotorasib + risperidone

    caution advised: combo may decr. risperidone levels, efficacy (hepatic metabolism induced)

  • ritlecitinib
  • Lumakras (sotorasib)
    +
    ritlecitinib
    1 interaction

    Caution Advised

    sotorasib + ritlecitinib

    caution advised: combo may decr. ritlecitinib levels, efficacy (hepatic metabolism induced)

  • ruxolitinib
  • Lumakras (sotorasib)
    +
    ruxolitinib
    1 interaction

    Caution Advised

    sotorasib + ruxolitinib

    caution advised: combo may decr. ruxolitinib levels, efficacy; may incr. active metabolite levels, risk of adverse effects (hepatic metabolism induced)

  • seladelpar
  • Lumakras (sotorasib)
    +
    seladelpar
    1 interaction

    Caution Advised

    sotorasib + seladelpar

    caution advised if also combined with OATP1B1 and/or OATP1B3 inhibitor: combo may incr. seladelpar levels, risk of adverse effects (BCRP-mediated transport inhibited)

  • silodosin
  • Lumakras (sotorasib)
    +
    silodosin
    1 interaction

    Caution Advised

    sotorasib + silodosin

    caution advised: combo may incr. silodosin levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • siponimod
  • Lumakras (sotorasib)
    +
    siponimod
    1 interaction

    Caution Advised

    sotorasib + siponimod

    if also combined w/ moderate or strong CYP2C9 inducer, caution advised; if CYP2C9*1/*3 or *2/*3 genotype, caution advised: combo may decr. siponimod levels, efficacy (hepatic metabolism induced)

  • sorafenib
  • Lumakras (sotorasib)
    +
    sorafenib
    1 interaction

    Caution Advised

    sotorasib + sorafenib

    caution advised: combo may decr. sorafenib levels, efficacy (hepatic metabolism induced)

  • sulfasalazine
  • Lumakras (sotorasib)
    +
    sulfasalazine
    1 interaction

    Caution Advised

    sotorasib + sulfasalazine

    caution advised: combo may incr. sulfasalazine levels, risk of adverse effects; may decr. IBD tx efficacy (gut BCRP-mediated transport inhibited)

  • sunitinib
  • Lumakras (sotorasib)
    +
    sunitinib
    1 interaction

    Caution Advised

    sotorasib + sunitinib

    caution advised: combo may decr. sunitinib levels, efficacy (hepatic metabolism induced)

  • suvorexant
  • Lumakras (sotorasib)
    +
    suvorexant
    1 interaction

    Caution Advised

    sotorasib + suvorexant

    caution advised: combo may decr. suvorexant levels, efficacy (hepatic metabolism induced)

  • telisotuzumab vedotin
  • Lumakras (sotorasib)
    +
    telisotuzumab vedotin
    1 interaction

    Caution Advised

    sotorasib + telisotuzumab vedotin

    caution advised: combo may decr. telisotuzumab vedotin levels, efficacy (hepatic metabolism induced)

  • terbinafine
  • Lumakras (sotorasib)
    +
    terbinafine
    1 interaction

    Caution Advised

    sotorasib + terbinafine

    caution advised: combo may decr. terbinafine levels, efficacy (hepatic metabolism induced)

  • tivozanib
  • Lumakras (sotorasib)
    +
    tivozanib
    1 interaction

    Caution Advised

    sotorasib + tivozanib

    caution advised: combo may decr. tivozanib levels, efficacy (hepatic metabolism induced)

  • trabectedin
  • Lumakras (sotorasib)
    +
    trabectedin
    1 interaction

    Caution Advised

    sotorasib + trabectedin

    caution advised: combo may decr. trabectedin levels, efficacy (hepatic metabolism induced)

  • trazodone
  • Lumakras (sotorasib)
    +
    trazodone
    1 interaction

    Caution Advised

    sotorasib + trazodone

    caution advised: combo may decr. trazodone levels, efficacy (hepatic metabolism induced)

  • tretinoin
  • Lumakras (sotorasib)
    +
    tretinoin
    1 interaction

    Caution Advised

    sotorasib + tretinoin

    caution advised: combo may decr. tretinoin levels, efficacy (hepatic metabolism induced)

  • triamcinolone
  • Lumakras (sotorasib)
    +
    triamcinolone
    1 interaction

    Caution Advised

    sotorasib + triamcinolone

    caution advised: combo may decr. triamcinolone levels, efficacy (hepatic metabolism induced)

  • triazolam
  • Lumakras (sotorasib)
    +
    triazolam
    1 interaction

    Caution Advised

    sotorasib + triazolam

    caution advised: combo may decr. triazolam levels, efficacy (hepatic metabolism induced)

  • tucatinib
  • Lumakras (sotorasib)
    +
    tucatinib
    1 interaction

    Caution Advised

    sotorasib + tucatinib

    caution advised: combo may decr. tucatinib levels, efficacy (hepatic metabolism induced)

  • upadacitinib
  • Lumakras (sotorasib)
    +
    upadacitinib
    1 interaction

    Caution Advised

    sotorasib + upadacitinib

    caution advised: combo may decr. upadacitinib levels, efficacy (hepatic metabolism induced)

  • vandetanib
  • Lumakras (sotorasib)
    +
    vandetanib
    1 interaction

    Caution Advised

    sotorasib + vandetanib

    caution advised: combo may decr. vandetanib levels, efficacy (hepatic metabolism induced)

  • vemurafenib
  • Lumakras (sotorasib)
    +
    vemurafenib
    1 interaction

    Caution Advised

    sotorasib + vemurafenib

    caution advised: combo may decr. vemurafenib levels, efficacy (hepatic metabolism induced)

  • vinblastine
  • Lumakras (sotorasib)
    +
    vinblastine
    1 interaction

    Caution Advised

    sotorasib + vinblastine

    caution advised: combo may decr. vinblastine levels, efficacy (hepatic metabolism induced)

  • vincristine
  • Lumakras (sotorasib)
    +
    vincristine
    1 interaction

    Caution Advised

    sotorasib + vincristine

    caution advised: combo may decr. vincristine levels, efficacy (hepatic metabolism induced)

  • vinorelbine
  • Lumakras (sotorasib)
    +
    vinorelbine
    1 interaction

    Caution Advised

    sotorasib + vinorelbine

    caution advised: combo may decr. vinorelbine levels, efficacy (hepatic metabolism induced)

  • vorapaxar
  • Lumakras (sotorasib)
    +
    vorapaxar
    1 interaction

    Caution Advised

    sotorasib + vorapaxar

    caution advised: combo may decr. vorapaxar levels, efficacy (hepatic metabolism induced)

  • zaleplon
  • Lumakras (sotorasib)
    +
    zaleplon
    1 interaction

    Caution Advised

    sotorasib + zaleplon

    caution advised: combo may decr. zaleplon levels, efficacy (hepatic metabolism induced)

  • zolpidem
  • Lumakras (sotorasib)
    +
    zolpidem
    1 interaction

    Caution Advised

    sotorasib + zolpidem

    caution advised: combo may decr. zolpidem levels, efficacy (hepatic metabolism induced)

  • zongertinib
  • Lumakras (sotorasib)
    +
    zongertinib
    1 interaction

    Caution Advised

    sotorasib + zongertinib

    caution advised: combo may decr. zongertinib levels, efficacy (hepatic metabolism induced)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@1116418
  • hepatotoxicity
  • interstitial lung disease
  • pneumonitis
  • pneumonia

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@3e543db2
  • diarrhea
  • musculoskeletal pain
  • nausea
  • fatigue
  • hepatotoxicity
  • cough
  • vomiting
  • constipation
  • dyspnea
  • abdominal pain
  • edema
  • appetite decr.
  • arthralgia
  • pneumonia
  • rash
  • lymphocytes decr.
  • Hgb decr.
  • ALT or AST incr.
  • calcium decr.
  • alk phos incr.
  • proteinuria
  • sodium decr.
  • aPTT incr.
  • albumin decr.

Safety/Monitoring .

Monitoring Parameters
LFTs at baseline, q3wk x3mo, then qmo or more frequently if elevated; signs/symptoms of interstitial lung disease

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy; no human data available; no known risk of teratogenicity or embryo-fetal death based on animal data at 2.6-4.6x systemic exposure, though risk of decr. fetal wt and reduced ossification at 2.6x systemic exposure

Lactation

Clinical Summary

avoid breastfeeding during tx and x1wk after D/C; no human data available to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@1d4f7d2a

Metabolism: for sotorasib: oxidation, conjugation; CYP450: 3A substrate

Excretion: for sotorasib: feces 74% (53% unchanged), urine 6% (1% unchanged); Half-life: 5h

Subclass: KRAS Inhibitors

Mechanism of Action
for sotorasib: irreversibly binds unique cysteine of KRAS G12C, blocking KRAS signaling, inhibiting cell growth, and promoting apoptosis in KRAS G12C-mutated tumor cells

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Amgen, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@5fe2720

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

oral tablet:

  • 120 mg (240 ea): $18,268.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information